Are all 21 compounds on this list equally serious from a regulatory standpoint?

No. The most serious are the Category 1B carcinogens: acetaldehyde, estragol, and methyl eugenol. These are prohibited in e-liquid under the EU Tobacco Products Directive at any concentration. The Category 2 substances are subject to concentration limits under REACH, but under the TPD's categorical prohibition for e-liquid they are also not permitted without strong justification. The solvents, hexane, toluene, and styrene, indicate a purification problem in the flavor manufacturing process rather than an intentional addition, and their presence needs to be investigated at the source.

Many of these compounds are natural. Why are they classified as CMR?

The CMR classification is based on the chemical properties of a compound and the evidence about its biological effects. Natural origin does not change those properties. Estragol occurs in basil. Methyl eugenol is in cinnamon. Acetaldehyde forms naturally during fermentation. The regulatory position is that for products designed to be inhaled, the safety standard is higher than for food, and that natural occurrence in food does not provide an exemption from CMR classification or the inhalation prohibition.

My supplier says their product is food-grade. Is that enough?

No. Food-grade compliance and e-liquid inhalation compliance are two different standards. A substance can be fully approved for use in food and still be prohibited in an inhalation product. Food-grade status was never assessed with inhalation in mind. A supplier declaration also reflects the formula as intended, not what analytical testing of the actual material would find. GC-MS analysis of the concentrate you actually receive is the only way to know what is really in it.

Does finding a CMR compound in my flavor mean my product has harmed consumers?

Finding a CMR compound in your formula does not mean your consumers have been definitively harmed. What it means is that your product cannot legally enter regulated export markets, and that it will not pass the additive safety testing required by PerBPOM 18/2025. The purpose of identifying these compounds is to give you the information you need to make the right decisions going forward, while you still have time to act on them.

How is the Strait of Hormuz closure actually affecting flavor shipments to Indonesia?

Before February 2026, sea freight from Europe to Indonesia took around 20 days. Since the closure forced shipping routes to divert around the Cape of Good Hope, that same journey now takes between 25 and 37 days. On top of the longer transit time, emergency bunker surcharges and war risk premiums have been added to shipping costs, making every order from a European flavor supplier more expensive and less predictable than it was a year ago. For brewers running lean inventory, the practical risk is a gap between when stock runs out and when the next shipment arrives.

China has cancelled its VAT export rebate on nicotine. What does that mean in practice for Indonesian brewers?

The 13% VAT export rebate that China previously offered functioned as a built-in cost subsidy that kept Chinese nicotine competitively priced on the global market. With that rebate removed from April 1, 2026, the factory cost of Chinese nicotine rises immediately, and those costs are passed along the supply chain. Indonesian brewers who source exclusively from China can expect to see nicotine input costs increase by somewhere between 8% and 15%. The practical response is to begin exploring Indian suppliers as an alternative or complementary source, which provides both a cost hedge and a supply continuity option if Chinese supply becomes further constrained.

With PP 28/2024 and PerBPOM 18/2025 taking effect in July 2026, what is the single most important thing a liquid manufacturer should be doing right now?

The most foundational step is understanding the complete chemical composition of every flavor you are currently using in production. Everything else that PerBPOM 18/2025 requires, including full ingredient disclosure to BPOM, additive safety testing, and cross-laboratory verification, depends on knowing what is actually in your formula at the compound level. Many manufacturers currently cannot answer this question because their flavor supplier never provided that information. Getting a GC-MS analysis done on your current flavors, either through your supplier or through an independent laboratory, is the step that makes all subsequent compliance work possible. Without it, you are filing documentation you cannot verify and testing for substances you may not even know are present.

Is there a realistic way to maintain supply continuity for European flavor concentrates given the current shipping disruptions?

Yes, but it requires adjusting both your logistics model and your inventory approach. On the logistics side, air freight from Europe to Indonesia runs at seven to nine days transit time regardless of what is happening in global shipping lanes, making it the only model that provides genuine predictability right now. The cost is higher than sea freight, but the alternative is building production schedules around 25 to 37 day transit times that are themselves subject to further delays. On the inventory side, moving from just-in-time stock levels to a buffer of four to eight weeks of critical flavor inputs significantly reduces the risk of a production stoppage caused by a delayed shipment. The combination of air freight for time-sensitive orders and strategic buffer stock for your core flavors is the most practical approach available in the current environment.

Does vaping actually cause popcorn lung?

This is one of the most repeated claims in public health discussions around vaping, and the honest answer is that the science does not currently support it as a straightforward fact. Popcorn lung, the common name for bronchiolitis obliterans, was first identified in factory workers who were inhaling heavily concentrated diacetyl fumes for hours every day over a period of years. The concentration levels involved were enormous compared to what is found in consumer e-liquid products. Despite diacetyl also being present in conventional cigarette smoke at levels hundreds of times higher than in e-cigarette aerosol, bronchiolitis obliterans has never emerged as a recognized smoking-related disease. To date, medical literature has not produced confirmed clinical cases of the condition definitively linked solely to e-cigarette use. This does not mean vaping is risk-free, but it does mean the specific popcorn lung claim goes beyond what current evidence actually confirms.

If diacetyl is banned in regulated markets, why is it still a concern for Indonesian producers?

Diacetyl is indeed banned in e-liquids across the UK and European Union, and most reputable manufacturers have removed it from their formulations. The concern for Indonesian producers comes from two directions. First, not all flavor concentrates circulating in the Indonesian market have been properly screened, and testing of local samples has found diacetyl-related compounds present in flavors where they were not declared. Second, and more technically important, is the precursor problem. A common substitute called acetoin is widely used as a safer replacement because it has a different chemical structure from diacetyl. However, research has shown that acetoin is chemically unstable in e-liquid over time and can slowly oxidize into diacetyl during storage, particularly in the presence of nicotine. A product that is genuinely diacetyl-free on the day it is manufactured may not remain so after several months on a shelf. This means the label alone is not sufficient assurance, and only regular GC-MS testing across the shelf life of the product provides a reliable answer.

What are the safer alternatives to diacetyl for creamy and custard flavor profiles?

The most scientifically sound approach for manufacturers who want to avoid diacetyl and its structural analogues entirely is to work with lactones. These are naturally occurring cyclic esters that provide dairy, peach, and coconut notes without the reactive chemical structure that makes diacetyl problematic for inhalation. Delta-decalactone delivers sweet, milky, and creamy notes with a soft peach character. Gamma-nonalactone provides a stronger coconut and fatty dairy quality. Delta-tetradecalactone is particularly effective at replicating the sensation of richness and full-fat creaminess, and research into the molecular composition of cream has identified it as a key contributor to that retronasal creamy perception. These lactone-based approaches require more sophisticated flavor chemistry than simply using a diketone compound, which is why they tend to be found in products from more technically capable manufacturers rather than budget operations. The result, however, is a creamy profile that does not carry the same inhalation risk profile as the compounds it replaces.

How can a producer verify that their current creamy or custard flavor is actually free of diacetyl and its precursors?

The only reliable method is GC-MS analysis, which stands for gas chromatography–mass spectrometry. This is the analytical technique that separates a flavor mixture into every individual compound it contains and identifies each one based on its unique molecular signature. It can detect diacetyl at trace levels that no other commonly available testing method can identify, and it can also flag the presence of acetoin so that the potential for future diacetyl formation through oxidation can be assessed. A standard sensory check or a supplier declaration of diacetyl-free status is not a substitute for this kind of analysis. Supplier declarations reflect the formula as it was made, not as it exists after months of storage. GC-MS testing of finished product samples at the time of manufacture and at intervals across the expected shelf life is the only approach that gives a producer a genuinely defensible answer to the question of whether their product contains diacetyl or compounds that will become diacetyl over time.

Is synthetic flavor the same as the flavor found in real fruit, or is it an inferior chemical substitute?

This is one of the most common misconceptions about how modern flavor chemistry works. Synthetic flavor molecules are not approximations of natural ones. They are chemically identical to the compounds found in the fruit itself. The molecule responsible for banana aroma, ethyl butyrate, is exactly the same whether it was extracted from an actual banana or built in a laboratory from butyric acid and ethanol. The difference is not in the molecule but in how it was obtained. Synthetic production is actually more consistent and often purer than natural extraction, which can introduce trace compounds from the source material that affect stability and quality. When a reputable flavor house produces a synthetic ester at 99% purity, the result is cleaner and more predictable than what natural extraction typically delivers. The word artificial carries negative connotations that the chemistry does not support.

If flavor ingredients are food-safe, why does it matter what concentration is used in an e-liquid?

Food safety assessments are conducted specifically for substances that are eaten and processed through the digestive system. When a compound is swallowed, it passes through the stomach, which provides an acidic protective environment, and then through the liver, which breaks down and neutralizes many chemicals before they reach the bloodstream. Inhalation bypasses all of this entirely. A compound that is inhaled reaches the lungs directly, crosses into the bloodstream almost immediately through the alveolar membrane, and arrives at the brain and other tissues faster and in higher concentrations than the same compound would if swallowed. The lungs have limited capacity to metabolize foreign chemicals compared to the liver. This means that a substance perfectly safe to consume in food can behave very differently when inhaled repeatedly at the concentrations found in e-liquid, which can be thousands of times higher than the levels present in natural fruit. Food-safe and inhalation-safe are two separate assessments, and assuming one covers the other is where the problem begins.

What makes one e-liquid flavor taste noticeably richer and more complex than another?

The difference almost always comes down to the depth and precision of the flavor formulation rather than the quality of a single ingredient. Premium flavor houses blend dozens of individual compounds in carefully calculated ratios to create layered profiles where different notes emerge at different points during inhalation and exhalation. Budget products tend to rely on a small number of inexpensive compounds at high concentrations, which produces a flat, one-dimensional taste that can also be harsher on the throat. The interaction between compounds matters as much as the compounds themselves. Adding small amounts of vanillin to a fruity blend, for example, enhances the perception of ripeness without the mixture tasting of vanilla. Ethyl maltol smooths the sharp edges of acidic citrus notes and adds a perception of sweetness without additional sugar. These synergistic relationships between molecules are what separates a well-engineered flavor from a simple one, and they require both scientific knowledge and sensory expertise to develop correctly.

How does a manufacturer know whether the flavors they are using are safe to inhale, not just safe to eat?

The honest answer is that without proper laboratory testing, they often do not. The most reliable method for verifying the safety of an e-liquid flavor at the compound level is GC-MS analysis, which stands for gas chromatography–mass spectrometry. This technique separates the flavor mixture into every individual molecule it contains and identifies each one, allowing a complete picture of what is actually present in the formula rather than what the supplier says is present. It can detect compounds like diacetyl at trace levels, identify CMR classified substances that should not be in an inhalation product, and flag anything that falls outside the permitted parameters for the markets the product is intended for. Beyond testing at the time of manufacture, stability testing across the expected shelf life of the product is also important, because some compounds that are safe when a product is first made can change chemically during storage. Responsible manufacturers conduct both, and they work with flavor suppliers who provide full technical documentation rather than general assurances.

Can a representative office in Indonesia sign contracts or receive payment from local customers?

No, and this is the most important limitation to understand before setting up a KPPA. A representative office is legally prohibited from conducting any commercial activity in Indonesia. This means it cannot issue invoices, receive payment for goods or services, sign commercial contracts on behalf of the parent company, or import physical goods. These prohibitions are absolute under Trade Law No. 7 of 2014, and operating commercially through a KPPA risks permit revocation and significant financial penalties. If your goal involves any form of revenue generation in Indonesia, you need a different legal structure, either a PT PMA, a distributor relationship, or an Importer of Record arrangement, to handle the commercial side of the business.

How long does it take to set up a representative office in Indonesia, and what does it cost?

A KPPA is one of the faster Indonesian legal structures to establish. The process typically takes between four and eight weeks depending on the completeness of the documentation provided and the sector the parent company operates in. There is no minimum capital requirement, which makes it significantly more accessible than a PT PMA. The main costs involved are government filing fees, notarial costs, and the ongoing operational expenses of maintaining an office and employing local staff. Because the KPPA cannot generate revenue, all of these costs must be funded by the parent company abroad, so the ongoing financial commitment needs to be factored into the decision alongside the setup cost.

What is the difference between a KPPA and a PT PMA, and how do you choose between them?

The fundamental difference is commercial capability. A KPPA is a non-commercial liaison office that can conduct market research, build relationships, and provide technical support but cannot generate any revenue. A PT PMA is a fully commercial Indonesian legal entity that can import goods, invoice customers, sign contracts, and employ staff directly, with the possibility of 100% foreign ownership in eligible sectors. The PT PMA requires a minimum investment plan of IDR 10 billion and takes several months to establish. The choice between them depends on what you need to do in Indonesia. If your immediate priority is market research and relationship building before committing to commercial operations, a KPPA may be the right first step. If you need to sell products and generate revenue from the start, a PT PMA or an Importer of Record arrangement is necessary.

Is it possible to use both a KPPA and an Importer of Record at the same time?

Yes, and this combination is increasingly common among foreign companies entering Indonesia in 2026. The two structures serve entirely different functions and complement each other well. The Importer of Record handles all commercial activity: importing goods, managing customs clearance and product registrations, invoicing local customers, and remitting revenue back to the foreign parent. The KPPA meanwhile employs a local team that oversees the relationship with the Importer of Record, builds direct relationships with key buyers and stakeholders, conducts market intelligence, and manages brand presence. This approach gives a foreign company both commercial capability and local presence from the early stages of market entry, without requiring the capital commitment of a PT PMA until the business case in Indonesia is fully proven.

Author: Petr

Big Tobacco Owns Indonesia

Indonesia is home to around 75 million smokers. More than 59% of adult men smoke. Every year, somewhere between 240,000 and 300,000 Indonesians die from tobacco-related illness. The government collects USD 12.9 billion in tobacco excise tax annually, while independent research puts the total economic cost of smoking, including healthcare and lost productivity, at more than USD 24 billion per year.

The country has not ratified the WHO Framework Convention on Tobacco Control. It is the only country in Southeast Asia that has not. It has no meaningful restrictions on tobacco advertising. Cigarettes can still be bought one stick at a time at kiosks next to schools. And the companies profiting most from all of this are not Indonesian. They are Philip Morris International from the United States, British American Tobacco from the United Kingdom, and Japan Tobacco International from Japan.

This is not an accident. It is the result of a systematic and decades-long process of corporate acquisition, political influence, and regulatory capture. Understanding how it happened is the first step toward understanding what the independent vape industry in Bandung and across Indonesia is actually up against.

How Three Global Companies Came to Own the Indonesian Cigarette Market

For most of the 20th century, Indonesia’s tobacco industry was built and owned by Indonesian families. The biggest names were household names: Sampoerna, founded in 1913 by Liem Seeng Tee in Surabaya; Bentoel, one of the country’s oldest tobacco companies; and the remaining major players Gudang Garam and Djarum, which remain locally controlled.

The shift began in 2005. Philip Morris International paid USD 5.2 billion to acquire what became a 97.95% stake in Sampoerna, the country’s largest cigarette company, through a combination of direct purchase and a public tender offer. At the time of the sale, Sampoerna controlled close to 20% of the Indonesian cigarette market. The company was not in financial trouble. It was at its peak. The founding family, led by Putera Sampoerna representing the third generation, chose to sell.

Today PMI holds 92.5% of Sampoerna after a 2015 rights issue required to meet stock exchange rules, with the remainder publicly traded. Sampoerna’s brands include Dji Sam Soe, Sampoerna A, and Marlboro.

In 2009, British American Tobacco paid USD 494 million for an 85% initial stake in Bentoel, Indonesia’s fourth largest cigarette company, then completed a public tender offer to bring its total stake to 99.74%. BAT’s stated reason for the acquisition was to enter the kretek market, where it had no presence. Indonesia’s kretek segment accounts for over 90% of domestic cigarette consumption.

In 2017, Japan Tobacco International acquired PT Karyadibya Mahardhika and its distributor PT Surya Mustika Nusantara for USD 677 million, giving it immediate nationwide scale in the Indonesian kretek market. Including the debt taken on as part of the deal, the total transaction value was closer to USD 1 billion.

The three companies now collectively control the majority of machine-made cigarette volume in Indonesia. The remaining major domestic players are Gudang Garam and Djarum, both still Indonesian-owned.

Why Indonesia Was the Target

The answer is straightforward. By the time these acquisitions happened, cigarette consumption in Europe, North America, and Australia was falling. Plain packaging laws, advertising bans, tax increases, and cultural shifts had turned what were once growth markets into declining ones. The global tobacco industry needed somewhere to grow.

Indonesia offered everything these companies were losing elsewhere. A huge population with high male smoking rates. Minimal advertising restrictions. A complex, multi-tiered excise tax system that kept cigarettes affordable. No FCTC ratification. A healthcare system not yet equipped to mount a meaningful public health response. And an established cultural relationship between tobacco and daily life that had been built over a century.

The acquisitions were not opportunistic. They were strategic. The world’s most powerful tobacco companies looked at Indonesia and saw a market that could sustain their global revenue as the rest of the world turned against them.

The Tax System That Keeps Cigarettes Cheap

One of the most important tools maintaining Indonesia’s smoking rates is not advertising. It is the excise tax structure itself.

Indonesia’s tobacco excise system has eight tiers, based on product type, production method, and price range. Machine-made kretek cigarettes are taxed at very different rates from hand-rolled ones. Tier 1 machine-made products from the largest companies carry the highest excise rates. Cheaper tiers, used by smaller producers, carry rates that can be less than one tenth of those applied to the top tier.

When the government raises excise taxes, smokers do not quit. They switch to cheaper products. A 2025 study by the Center for Indonesia’s Strategic Development Initiatives found that 35.73% of smokers switched to cheaper alternatives when prices rose. The system was originally designed to protect small producers, but in practice it guarantees there is always an affordable option, which removes the public health impact that higher prices are supposed to have.

The government collected IDR 216.9 trillion, or approximately USD 12.9 billion, in tobacco excise in 2024. The estimated total economic cost of smoking that same year, counting healthcare spending and lost productivity, ran to multiples of that figure. Indonesia is taxing tobacco and losing money on the trade.

Children Are the Market

The tobacco industry’s long-term strategy anywhere in the world has always been the same: replace the smokers who die with new ones. In Indonesia, that replacement pool is children.

The 2023 Indonesia Health Survey found 5.2 million teenage and preadolescent smokers. The Tobacco Atlas puts youth smoking prevalence at 8.48%. A government target set in the National Medium-Term Development Plan aimed to reduce child smoking to 5.4%. That target has not been met.

The mechanisms are not complicated. Cigarettes are available as single sticks at kiosks throughout the country, including those close to schools. The practice is called ketengan. Although PP 28/2024 prohibits single-stick sales, enforcement on the ground remains minimal. A child can buy a cigarette for the price of a small snack.

Tobacco advertising remains pervasive in public spaces and social media, using imagery designed to appeal to younger consumers. More than 70% of adult men smoke, which means smoking is normalized in the home, at social gatherings, and in public spaces children move through every day.

What Smoking Costs Indonesia’s Healthcare System

BPJS Kesehatan, Indonesia’s national health insurance system, is in deficit. The primary driver is the cost of treating non-communicable diseases including heart disease, stroke, cancer, and chronic respiratory conditions, all of which are caused or worsened by tobacco.

A peer-reviewed study published in the medical literature found that BPJS allocated between IDR 10.4 trillion and IDR 15.6 trillion to cover healthcare costs attributable to smoking in 2019 alone, representing between 61% and 91.8% of that year’s total BPJS deficit. The numbers have grown since.

More than 70% of cancer patients in Indonesia are diagnosed at stage three or four, when treatment options are limited and outcomes are poor. The country has approximately 140 medical oncologists and 200 surgical oncologists for a population of over 270 million people. An estimated 90% of cancer patients outside Jakarta cannot access radiotherapy. The people dying are not dying because treatment does not exist. They are dying because the system built to protect them was not built to cope with the scale of what tobacco has done to this country.

The Corruption Layer

In February 2026, Indonesia’s Corruption Eradication Commission named Budiman Bayu Prasojo, head of the Intelligence Section for Excise Enforcement and Investigation at the Directorate General of Customs and Excise, as a suspect in a corruption probe. Investigators found that cigarette importing companies had provided bribes and gratuities to customs officials to manipulate excise payments and import clearance. Approximately IDR 5.19 billion in cash was seized from a safe house in Ciputat. One company identified in the investigation, Blueray, had its owner reportedly flee during initial arrests.

This is not an isolated incident. It is the visible surface of a system where the financial stakes are so high that regulatory capture extends from the lobbying rooms of parliament down to individual enforcement officials.

Indonesia Has Not Ratified the FCTC. Here Is Why.

The WHO Framework Convention on Tobacco Control is the international treaty that establishes minimum standards for tobacco regulation. Every country in Southeast Asia has ratified it. Indonesia has not.

The official argument is national sovereignty and the protection of tobacco farmers. The real explanation is that the tobacco industry has been more effective at shaping domestic political outcomes than the public health community. Responsibility for tobacco policy in Indonesia is fragmented across nine government ministries. The Ministry of Finance and the Ministry of Industry, both of which have strong interests in tobacco revenue and industrial output, consistently outweigh the Ministry of Health when policies conflict.

This fragmentation is not accidental. An industry with the resources of PMI, BAT, and JTI operating in a market where regulatory consolidation would hurt their business has every incentive to ensure that consolidation never happens. And for decades, it has not.

The Bandung Vape Scene and Why It Matters

In Bandung and across Indonesia, an independent vape culture has developed that is unlike anything the tobacco industry built. Small producers, known locally as brewers, developed their own flavor profiles, invested in their own equipment, built their own communities, and created a market that reached a value of nearly USD 240 million by 2021.

These are not subsidiaries of global corporations. They are local businesses. Many of the people running them started because they wanted to quit smoking and found vaping more effective than anything else they had tried. The products they make are positioned explicitly as alternatives to combustible tobacco, aimed at adult smokers who are looking for a way out.

The tension between this community and Big Tobacco is real. PMI has entered the heat-not-burn market through IQOS, investing more than USD 186 million in manufacturing facilities in Karawang. The global tobacco companies understand that the combustible cigarette market will eventually decline, and they are positioning themselves in the next market before it fully arrives, using the same resources and distribution networks they built on conventional tobacco.

An independent brewer in Bandung does not have those resources. But they do have things the global companies cannot easily replicate: genuine product knowledge, a direct connection to their consumer community, and the trust that comes from being part of the same culture as the people buying their products.

What the Bandung Brewers Are Actually Up Against

The regulatory environment heading into the second half of 2026 is the most challenging the independent vape industry has faced.

PP 28/2024 and PerBPOM 18/2025 take full effect on July 26, 2026. Mandatory ingredient disclosure to BPOM, additive safety testing with cross-laboratory verification, packaging restrictions to 10ml and 20ml formats, a minimum purchase age of 21, and advertising bans are all coming simultaneously. Each of these individually is manageable. Together, in a short timeframe, they represent a significant compliance burden.

The BNN proposal to classify vape devices under narcotics and psychotropics legislation is the more existential threat. The BNN has cited laboratory tests finding 35 out of 341 vape liquid samples containing illegal substances including synthetic cannabinoids and methamphetamine. The response proposed is a total ban. Independent producers point out that this conflates products made by compliant, documented manufacturers with illicit drug-laced liquids, and that a total ban would eliminate the legitimate industry while the drug-laced products would simply find other distribution channels.

The suspicion within the independent industry that this narrative is being amplified by interests that would benefit from eliminating competition from independent producers is understandable given the history. It is also impossible to prove. What is clear is that the legitimate independent vape industry needs a different strategy than simply hoping the regulation goes away.

What Independent Producers Need to Do to Actually Have a Chance

Compliance is not optional and it is not the enemy. Compliant producers are protected. Non-compliant ones are exposed, and a ban justified by drug-laced products from non-compliant operations will sweep away compliant ones too if the industry cannot clearly demonstrate the distinction.

The first priority is documentation. Every flavor in every product needs compound-level documentation. Every formula needs to be verified by GC-MS testing. Every batch needs to be traceable. This is what separates a legitimate producer from an illicit one in the eyes of a regulator, a buyer, and a court. Producers who cannot demonstrate this are a liability to the entire industry’s case for continued existence.

The second priority is unity. The independent vape industry in Indonesia is fragmented. Individual brewers protecting individual formulas and individual market positions are easy to dismiss and easy to regulate out of existence. A credible industry association that can present documented safety data, engage with BPOM on the terms of PerBPOM 18/2025, and make the public health case for regulated vaping as a tobacco harm reduction tool is something that cannot be ignored. This conversation is happening in the UK, Australia, and New Zealand. It needs to happen in Indonesia.

The third priority is the public health argument. The tobacco industry cannot make this argument. A company that profits from selling combustible cigarettes to 75 million Indonesians, including children, cannot credibly position itself as a public health partner. Independent vape producers can make that argument, but only if they can back it up with documented safety, transparent ingredients, and a clear message about who their products are for and who they are not for.

The fourth priority is export readiness. The domestic market is under pressure. Export markets in Singapore, Australia, and other ASEAN countries represent real demand for products that can demonstrate regulatory credibility. Indonesian brewers who build compliance infrastructure now are positioned to access those markets. Those who do not are not.

The vape industry in Indonesia did not create the public health crisis that Big Tobacco built over a century. But it is operating in the shadow of that crisis and will be judged by it. The only way through is to be demonstrably different, and to be able to prove it.

When did global tobacco companies take control of Indonesia’s cigarette market, and how much did they pay?

The process happened in three major transactions over twelve years. Philip Morris International acquired what became a 97.95% stake in Sampoerna in 2005 for USD 5.2 billion, including debt. PMI currently holds 92.5% after a 2015 stock exchange rights issue. British American Tobacco acquired 99.74% of Bentoel in 2009 for approximately USD 580 million through an initial purchase and subsequent public tender offer. Japan Tobacco International acquired PT Karyadibya Mahardhika and its distributor in 2017 for USD 677 million, with the total transaction value including debt closer to USD 1 billion. These three companies now control the majority of machine-made cigarette volume in Indonesia. The remaining major domestic players, Gudang Garam and Djarum, remain Indonesian-owned.

Why are cigarettes still so cheap in Indonesia despite tax increases every year?

Indonesia’s tobacco excise system has eight tiers based on product type, production method, and price range. When taxes go up on expensive tier one products, smokers switch to cheaper lower-tier products rather than quitting. A 2025 study found that 35.73% of smokers actively downtraded to cheaper alternatives when prices rose. The system was designed to protect small producers but in practice it guarantees there is always an affordable cigarette available. The government collected USD 12.9 billion in excise in 2024 while the economic cost of smoking, counting healthcare and lost productivity, runs to multiples of that figure. Indonesia is effectively subsidizing the health consequences of a habit it taxes.

What is the BNN’s proposal to ban vaping and how serious is it?

The National Narcotics Agency has proposed classifying vape devices under Indonesia’s narcotics and psychotropics legislation, which would result in a total ban. The stated basis is laboratory testing finding 35 out of 341 vape liquid samples contained illegal substances including synthetic cannabinoids and methamphetamine. The proposal has not yet been enacted into law. The independent vape industry argues that the proposal conflates compliant, documented products with illicit drug-laced liquids and that a total ban would eliminate legitimate businesses without addressing the actual drug problem. The threat is real and requires a coordinated industry response with documented safety evidence rather than individual advocacy.

What does a Bandung brewer actually need to do to survive and grow in this regulatory environment?

Four things matter more than anything else right now. The first is documentation. Every flavor needs compound-level GC-MS verified analysis showing it is free of prohibited substances. This is what separates a legitimate product from an illicit one in the eyes of any regulator. The second is industry unity. Individual producers fighting individually are easy to dismiss. A credible association that can engage with BPOM and make the harm reduction case with data behind it is far harder to ignore. The third is the public health argument. Independent producers have the credibility to make the case for regulated vaping as an alternative to combustible tobacco. Big Tobacco cannot make that argument. The fourth is export readiness. Compliant producers with full documentation can access Singapore, Australia, and other ASEAN markets. That is a significant hedge against domestic regulatory pressure and a reason to build compliance infrastructure now rather than later.

April 24, 2026
CMR Flavor Chemicals in E-Liquid: What Indonesian Brewers Need to Know

If you produce e-liquid in Indonesia and you have been hearing more about CMR substances recently, this article is for you. The regulations are changing and the compounds inside your flavor concentrates matter more than they did couple of years ago.

Here is what CMR means, which compounds are on the list, and what you need to do.

What CMR Means

CMR stands for Carcinogenic, Mutagenic, or Reprotoxic. It is the classification system used by the European Chemicals Agency to identify chemicals that may cause cancer, genetic damage, or harm to reproduction.

There are two categories. Category 1 means the harm is confirmed or strongly indicated based on scientific evidence. Category 2 means there is reasonable suspicion of harm based on available data.

Under EU law, Category 1 CMR substances are prohibited in consumer products above very low concentration limits. Under the EU Tobacco Products Directive, any substance with CMR properties is prohibited in e-liquid entirely, regardless of concentration. There is no permitted level. The prohibition is absolute.

Indonesia’s own PerBPOM 18/2025, which takes full effect on July 26, 2026, requires full ingredient disclosure to BPOM and laboratory-verified proof that your additives are safe. If your formula contains a CMR substance, you will not be able to meet this requirement.

Why This Matters for Your Business

There are two practical consequences.

The first is export. If your e-liquid contains a CMR substance in its flavor formula, it cannot enter the EU, UK, or any market aligned with those standards. This applies regardless of how small the concentration is in the final bottle.

The second is domestic compliance. From July 26, 2026, you are required to disclose every ingredient in your product to BPOM and provide safety testing evidence. CMR substances will fail that test.

The 21 Compounds on the List

The following compounds have been identified by Argeville’s regulatory team as CMR-classified substances found in flavor samples from the Indonesian and Southeast Asian market. Each one is a real flavor ingredient used in real products. Many of them appear in flavors that are popular and widely used right now.

Acetaldehyde is a fresh, fruity aldehyde found naturally in fruit and coffee. It is classified as a Category 1B carcinogen. It is specifically tested for in EU and UK e-cigarette emissions assessments and is not permitted in regulated e-liquid formulas.

Acetophenone provides sweet, almond, and floral notes used in fruit and nut flavors. It is classified as Category 2 for reproductive toxicity.

Anisaldehyde delivers sweet, floral, and anise-like character used in oriental flavor profiles. It is classified as Category 2 for reproductive toxicity.

Benzaldehyde is the compound behind cherry and almond flavors. It is one of the most widely used flavor chemicals in e-liquid globally, found in around 31% of products tested in published research. It is classified as Category 2 for reproductive toxicity. Its widespread use makes it one of the most commonly present CMR substances in undocumented flavor concentrates in Indonesia.

Cumin aldehyde provides warm, spicy, and herbal notes from cumin. It is classified as Category 2 for reproductive toxicity.

Cyclamen aldehyde is a synthetic compound used in floral and green applications. It is classified as Category 2 for reproductive toxicity.

Delta-3-carene is a terpene found in pine and citrus oils contributing fresh, woody, and sweet notes. It is classified as Category 2 for reproductive toxicity and is a known respiratory irritant at higher concentrations.

Diphenyl oxide has a floral, geranium-like character used in certain floral formulations. It is classified as Category 2 for reproductive toxicity. Testing of Indonesian market samples has found it at concentrations between 0.2% and 0.6% inside flavor concentrates. That is a significant level for a compound with this classification.

Estragol is found naturally in basil, tarragon, and anise and provides sweet, herbal, and spicy notes. It is classified as a Category 1B carcinogen. Research on e-liquid composition has found estragol at levels high enough to present a calculated cancer risk in some products. Under the EU TPD it is not permitted in e-liquid at any level.

Furfural provides warm, woody, bready, and almond notes used in coffee and caramel profiles. It is classified as a Category 2 carcinogen. It has been detected in e-cigarette aerosol in published studies, and its levels increase with device power and the presence of sweeteners in the formula.

Gamma-terpinene is a citrus terpene from thyme and coriander contributing fresh, herbal notes. It is classified as Category 2 for reproductive toxicity.

Heliotropin, also known as piperonal, provides sweet, floral, vanilla-like notes and is used widely in dessert and oriental profiles. It is on the IFRA restricted list and international buyers are increasingly requiring zero inclusion as a condition of purchase.

Hexane is an industrial solvent that can appear in flavor concentrates as a residual from natural extraction processes. It is classified as Category 2 for reproductive toxicity. Its presence in a concentrate means the raw material was not sufficiently purified.

Isophorone is a minty, camphoraceous ketone used in some complex flavor applications. It is classified as Category 2 for carcinogenicity.

Keto-isophorone is a related compound used in floral and woody applications. It is classified as Category 2 for carcinogenicity.

Methyl benzoate is a fruity, floral ester found naturally in cloves and ylang-ylang. It is classified as Category 2 for reproductive toxicity.

Methyl eugenol provides sweet, spicy, and clove-like notes found naturally in basil and cinnamon. It is classified as a Category 1B carcinogen. Under the EU TPD it is not permitted in e-liquid at any level.

Methyl salicylate is the compound behind wintergreen flavor, widely used in mint and cooling profiles. It carries a specific EU restriction for products accessible to consumers under 18. For any brand selling internationally, its presence requires documented justification.

Para-cymene provides warm, spicy, herbal notes from thyme and cumin. It is classified as Category 2 for reproductive toxicity.

Styrene is an industrial chemical that can appear in e-liquid as a contamination or degradation product from certain flavor components or heating processes. It is classified as Category 2 for carcinogenicity. Traces have been detected in e-cigarette vapor in multiple studies. Its presence in a formula requires immediate investigation.

Toluene is a solvent that can appear as a residual in flavor concentrates made from certain aromatic raw materials. It is classified as Category 2 for reproductive toxicity with well-documented effects on fetal development. Like hexane, its presence indicates a purification problem in the source material.

The Most Important Question to Ask Right Now

Do you know whether any of these 21 compounds are present in the flavor concentrates you are currently using?

Most Indonesian producers cannot answer that question. Their supplier never provided the compound-level documentation needed to know. A general product description or a food-grade safety certificate does not tell you which specific chemicals are in the formula.

The only way to get a definitive answer is GC-MS analysis of the actual flavor material. This test separates the concentrate into every individual compound it contains and identifies each one. It tells you exactly what is in your formula, including anything your supplier did not disclose.

What You Should Do Before July 2026

Ask your flavor supplier for a full technical datasheet showing every compound in the formula and its regulatory classification under EU REACH and IFRA standards. A supplier with properly documented, compliant formulas will have this document ready.

If your supplier cannot provide it, get your flavors tested independently before you submit anything to BPOM. Finding a CMR compound after you have already filed your ingredient disclosure is a far more difficult situation than finding it now while you still have time to reformulate.

Reformulation takes time. Re-registration takes time. Starting now puts you in control of that process.

If you are based in Indonesia and need access to GC-MS testing or compliant flavor documentation, we are based in Bandung and work with a certified R&D laboratory in France. We are happy to help.

Are all 21 compounds on this list equally serious from a regulatory standpoint?

No. The most serious are the Category 1B carcinogens: acetaldehyde, estragol, and methyl eugenol. These are prohibited in e-liquid under the EU Tobacco Products Directive at any concentration. The Category 2 substances are subject to concentration limits under REACH, but under the TPD’s categorical prohibition for e-liquid they are also not permitted without strong justification. The solvents, hexane, toluene, and styrene, indicate a purification problem in the flavor manufacturing process rather than an intentional addition, and their presence needs to be investigated at the source.

Many of these compounds are natural. Why are they classified as CMR?

The CMR classification is based on the chemical properties of a compound and the evidence about its biological effects. Natural origin does not change those properties. Estragol occurs in basil. Methyl eugenol is in cinnamon. Acetaldehyde forms naturally during fermentation. The regulatory position is that for products designed to be inhaled, the safety standard is higher than for food, and that natural occurrence in food does not provide an exemption from CMR classification or the inhalation prohibition.

My supplier says their product is food-grade. Is that enough?

No. Food-grade compliance and e-liquid inhalation compliance are two different standards. A substance can be fully approved for use in food and still be prohibited in an inhalation product. Food-grade status was never assessed with inhalation in mind. A supplier declaration also reflects the formula as intended, not what analytical testing of the actual material would find. GC-MS analysis of the concentrate you actually receive is the only way to know what is really in it.

Does finding a CMR compound in my flavor mean my product has harmed consumers?

Finding a CMR compound in your formula does not mean your consumers have been definitively harmed. What it means is that your product cannot legally enter regulated export markets, and that it will not pass the additive safety testing required by PerBPOM 18/2025. The purpose of identifying these compounds is to give you the information you need to make the right decisions going forward, while you still have time to act on them.

April 23, 2026
The World Changed in 2026. Here Is What It Means for Indonesian Vape Manufacturers.

In late February 2026, a coordinated military escalation in the Middle East effectively closed the Strait of Hormuz, one of the most critical chokepoints in global maritime trade. Within days, the major shipping lines suspended operations through the Persian Gulf. Within weeks, the ripple effects had reached every corner of the global manufacturing economy, including the Indonesian e-liquid industry.

This is not a temporary disruption waiting to resolve itself. It is a structural shift in how goods move around the world, arriving at exactly the same moment that Indonesia’s own regulatory environment is undergoing its most significant transformation in over a decade. For liquid manufacturers in Indonesia, understanding what is happening and responding to it systematically is the difference between a business that navigates this period well and one that gets caught short.

This article explains the key forces at play, what they mean concretely for Indonesian brewers, and the practical steps that can be taken now to build a more resilient operation.

What Happened at the Strait of Hormuz

The Strait of Hormuz handles roughly 11% of all global seaborne trade. Before the February 2026 escalation, approximately 153 vessels passed through it every day. By the first week of March, that number had fallen to fewer than 5. Maersk, MSC, Hapag-Lloyd, and CMA CGM all formally suspended Persian Gulf operations. Approximately 170 container ships carrying 450,000 TEUs of cargo were effectively stranded.

The consequences spread outward in several directions simultaneously.

Oil prices spiked past 100 dollars per barrel and peaked above 110 dollars as markets absorbed the loss of roughly 20% of the global oil supply that normally moves through the strait. Higher energy costs function as a tax on everything: factory power, chemical synthesis, refrigeration, and last-mile delivery all became more expensive almost overnight.

Shipping routes from Europe to Asia were forced to divert around the Cape of Good Hope, adding significant time and cost to every journey. A shipment from the United Kingdom to Jakarta that previously took around 20 days now takes between 25 and 37 days. Container rates, which had already been elevated, climbed further. Emergency bunker surcharges were introduced on top of existing freight rates. War risk surcharges appeared on air cargo routes passing near conflict zones.

For an industry built on relatively fast inventory turnover and a globalized supply of components, this created an immediate gap between supply and demand that will take months to normalize.

What This Means for Indonesian Brewers Specifically

Indonesian liquid manufacturers depend on four core inputs: propylene glycol, vegetable glycerin, nicotine, and flavor concentrates. Each of these is being affected by the current environment in a different way.

Propylene glycol and vegetable glycerin prices in Southeast Asia remain higher than in Northeast Asia, running at roughly 1.19 dollars per kilogram compared to 0.95 dollars in China. VG supply is also sensitive to palm oil market movements, and crude palm oil reference prices in Indonesia rose to over 938 dollars per metric ton in March 2026, adding further pressure to input costs.

Nicotine supply from China, which is the primary source for most Indonesian brewers, is being affected by a significant policy change. China cancelled its 13% VAT export rebate on nicotine products effective April 1, 2026. This rebate had historically functioned as a cost subsidy that kept Chinese nicotine competitively priced on the global market. Without it, export costs from China are expected to rise by between 8% and 15%, translating directly into higher input costs for brewers who have not already diversified their sourcing.

Flavor concentrates present perhaps the most complex challenge. The premium end of the Indonesian e-liquid market has long depended on Overseas flavor houses for complex profile development and consistent quality. Major suppliers including Givaudan from Switzerland and Symrise and Hertz and Selck from Germany provide formulations that are difficult to replicate domestically. These suppliers are themselves under cost pressure, with energy and input costs rising, and the logistics of getting their products to Indonesia have become significantly more expensive and less predictable.

The Regulatory Layer on Top of All This

The supply chain disruption is arriving at a moment when Indonesian brewers are also managing the most demanding domestic regulatory transition in the industry’s history.

PP 28/2024 and PerBPOM 18/2025 take full effect on July 26, 2026, introducing mandatory ingredient disclosure to BPOM, additive safety testing requirements, packaging size restrictions to 10ml and 20ml formats, a minimum purchase age of 21, and significant advertising restrictions. Each of these changes requires operational adjustments, and several of them require investments of time and documentation that cannot be rushed.

The mandatory Halal certification deadline of October 17, 2026 adds another layer. From that date, flavoring agents and chemical goods used in consumer products must carry Halal certification or face exclusion from major retail and e-commerce platforms. Every component in an e-liquid formula, from base PG and VG to complex botanical extracts in flavor concentrates, needs to be traceable to its origin and certifiable under the Halal framework.

There is also the ongoing proposal from the National Narcotics Agency to include vaporizer components in a broad narcotics and psychotropics bill, driven by findings that a significant number of vape liquid samples tested in Indonesia contained illegal substances including synthetic cannabinoids and methamphetamine. While this proposal has not yet been enacted, it creates reputational and regulatory risk for the entire industry and strengthens the case for manufacturers who can demonstrate rigorous internal testing and clean supply chains.

What a More Resilient Supply Chain Actually Looks Like

The response to all of this is planning. The brewers who will be in the strongest position a year from now are those who are making deliberate changes to how they source, stock, and document their inputs.

The first area to address is inventory strategy. The era of just-in-time importing from European and other overseas flavor suppliers is effectively over for the near term. Lead times have lengthened, costs have risen, and the predictability that made lean inventory sensible no longer exists. Brewers who are still operating on minimal stock buffers are one shipping disruption away from a production stoppage. Moving to a higher inventory buffer of four to eight weeks of critical inputs, particularly flavor concentrates, is a straightforward adjustment that significantly reduces operational vulnerability.

The second area is sourcing diversification. Dependence on a single supplier or a single country of origin for any critical input is a structural risk that the current environment has made very visible. For nicotine, exploring Indian suppliers alongside Chinese ones provides a hedge against the VAT rebate removal and any further Chinese policy changes. For base materials, understanding which regional suppliers can provide USP-grade PG and VG at acceptable quality and cost gives you options that a single-supplier relationship does not.

For flavor concentrates, the diversification question is more nuanced because quality and compliance documentation are harder to verify quickly. The right move here is not to simply find cheaper alternatives, but to identify suppliers who can provide both the quality profile you need and the technical documentation that PerBPOM 18/2025 now requires. A flavor that arrives without a complete chemical compound datasheet is a liability in the current regulatory environment, regardless of how good it tastes.

The third area is logistics planning. Air freight has become the de facto contingency option for time-sensitive inputs, and building it into your cost planning rather than treating it as an emergency expense is a more honest reflection of the current reality. Air transit from Europe to Jakarta runs at seven to nine days, compared to the 25 to 37 days now typical for sea freight via the Cape of Good Hope. The cost difference is real, but so is the value of supply continuity when you have production commitments and retail deadlines to meet.

Understanding which of your inputs genuinely justify air freight pricing and which can tolerate longer sea freight lead times with appropriate buffer stock is a planning exercise worth doing systematically rather than under pressure.

The fourth area is documentation and compliance preparation. This is the area most easily deferred and the one that creates the most serious problems when it is. The ingredient disclosure requirements of PerBPOM 18/2025, the Halal certification process, and the additive safety testing requirements all take time to complete properly. Brewers who begin this process now, while there is still time to identify and address any formula-level issues, are in a fundamentally different position from those who begin it in June when the deadline is weeks away.

Starting with a complete inventory of what is in every flavor you currently use is the logical first step. From there, you can assess which formulas are already compliant, which require reformulation, and which suppliers are equipped to support the documentation requirements you now have to meet.

The Competitive Opportunity in All of This

It is worth stepping back and noting something that tends to get lost in the stress of managing multiple pressures simultaneously. The same forces that are making life harder for Indonesian brewers are creating a meaningful competitive opening.

China’s removal of the VAT export rebate is already incentivizing a shift in manufacturing toward Indonesia, particularly in free-trade zones like Batam. Indonesian producers who are compliant, documented, and able to demonstrate clean supply chains are well positioned to absorb that demand. The consolidation that tighter regulation typically produces means that manufacturers who navigate this period successfully emerge with a stronger market position than they had going in.

Export markets that have long been out of reach because of documentation requirements are becoming more accessible to Indonesian manufacturers who are investing in compliance infrastructure now. Singapore, Australia, and the broader ASEAN region represent significant demand for products that can demonstrate regulatory credibility.

The manufacturers who will capture that opportunity are those who treat the current disruption not as something to survive but as a forcing function for building the kind of operation that can compete in a more demanding market.

Where Arkadia Comes In

We are the Indonesian representative of Argeville, a France-based flavor manufacturer with a certified R&D laboratory serving more than 50 countries. We understand the current supply chain environment because we are operating directly within it.

One of the things that distinguishes how we work is that we import flavor concentrates from France via air freight as a standard practice rather than an emergency measure. It is the only logistics model that provides genuine supply continuity.

Beyond logistics, every flavor we supply comes with complete technical documentation including full chemical compound composition and regulatory status under EU REACH and IFRA standards. In the context of PerBPOM 18/2025 ingredient disclosure requirements and the upcoming Halal certification deadline. That’s what you need to operate legally and to access the markets you are targeting.

The supply chain is more complex than it was a year ago. The regulatory environment is more demanding. The brewers who respond to that reality with clear thinking and deliberate action are the ones who will be in the best position when the dust settles. We are here to help with the part of that picture that involves flavor.

FAQ

How is the Strait of Hormuz closure actually affecting flavor shipments to Indonesia?

Before February 2026, sea freight from Europe to Indonesia took around 20 days. Since the closure forced shipping routes to divert around the Cape of Good Hope, that same journey now takes between 25 and 37 days. On top of the longer transit time, emergency bunker surcharges and war risk premiums have been added to shipping costs, making every order from a European flavor supplier more expensive and less predictable than it was a year ago. For brewers running lean inventory, the practical risk is a gap between when stock runs out and when the next shipment arrives.

China has cancelled its VAT export rebate on nicotine. What does that mean in practice for Indonesian brewers?

The 13% VAT export rebate that China previously offered functioned as a built-in cost subsidy that kept Chinese nicotine competitively priced on the global market. With that rebate removed from April 1, 2026, the factory cost of Chinese nicotine rises immediately, and those costs are passed along the supply chain. Indonesian brewers who source exclusively from China can expect to see nicotine input costs increase by somewhere between 8% and 15%. The practical response is to begin exploring Indian suppliers as an alternative or complementary source, which provides both a cost hedge and a supply continuity option if Chinese supply becomes further constrained.

With PP 28/2024 and PerBPOM 18/2025 taking effect in July 2026, what is the single most important thing a liquid manufacturer should be doing right now?

The most foundational step is understanding the complete chemical composition of every flavor you are currently using in production. Everything else that PerBPOM 18/2025 requires, including full ingredient disclosure to BPOM, additive safety testing, and cross-laboratory verification, depends on knowing what is actually in your formula at the compound level. Many manufacturers currently cannot answer this question because their flavor supplier never provided that information. Getting a GC-MS analysis done on your current flavors, either through your supplier or through an independent laboratory, is the step that makes all subsequent compliance work possible. Without it, you are filing documentation you cannot verify and testing for substances you may not even know are present.

Is there a realistic way to maintain supply continuity for European flavor concentrates given the current shipping disruptions?

Yes, but it requires adjusting both your logistics model and your inventory approach. On the logistics side, air freight from Europe to Indonesia runs at seven to nine days transit time regardless of what is happening in global shipping lanes, making it the only model that provides genuine predictability right now. The cost is higher than sea freight, but the alternative is building production schedules around 25 to 37 day transit times that are themselves subject to further delays. On the inventory side, moving from just-in-time stock levels to a buffer of four to eight weeks of critical flavor inputs significantly reduces the risk of a production stoppage caused by a delayed shipment. The combination of air freight for time-sensitive orders and strategic buffer stock for your core flavors is the most practical approach available in the current environment.

April 20, 2026
Popcorn Lung and Vaping: What the Science Actually Says

Few health claims in the vaping world get repeated as often as this one: vaping causes popcorn lung. It shows up in news headlines, health warnings, and social media posts with remarkable confidence. The reality, as with most things in science, is considerably more nuanced and understanding that nuance is essential for anyone producing or formulating e-liquids responsibly.

What Is Popcorn Lung?

Popcorn lung is the common name for bronchiolitis obliterans, a rare, serious, and irreversible lung disease. It involves inflammation and permanent scarring of the bronchioles, the smallest airways in the lungs. Once scarred, these airways cannot be repaired. The result is progressive loss of lung function, persistent dry cough, and increasing shortness of breath.

The nickname came from a 2000 investigation at a microwave popcorn factory in Missouri, where workers developed the condition after prolonged exposure to heavily concentrated diacetyl fumes during heated industrial mixing processes, breathing high levels for hours every working day, over years.

The Diacetyl Problem in E-Liquid

Diacetyl is a naturally occurring compound found in butter, beer, coffee, and fermented foods. It is perfectly safe to eat. The problem arises specifically with inhalation, and it became relevant to vaping when researchers found it present in e-liquid formulas, particularly in dessert, custard, and cream flavored products.

A widely cited Harvard study found diacetyl in 39 out of 51 tested e-liquid flavors. This understandably raised alarm, and the industry response was swift. Most reputable manufacturers moved to remove diacetyl from their formulations, and it is now strictly banned in e-liquids across the UK and European Union.

For Indonesian producers asking whether they should be concerned about diacetyl: yes, eliminating it from your formulations is the right call. The regulatory direction globally is clear, and consumer awareness of the issue is growing. The more important question, however, is what you replace it with and how you verify that the replacement is actually doing its job safely.

Where the Science Gets More Complicated

The connection between vaping and actual diagnosed cases of popcorn lung is weaker than most headlines suggest. It is important to be accurate about this, not to dismiss the concern, but to understand it properly.

Diacetyl is also present in traditional cigarette smoke at levels estimated to be hundreds of times higher than those found in e-cigarette aerosol. Yet bronchiolitis obliterans has never emerged as a recognized smoking-related disease despite decades of cigarette use by hundreds of millions of people. This dose-response disparity is significant and has been noted repeatedly by clinical researchers.

Furthermore, medical literature has not produced confirmed clinical cases of bronchiolitis obliterans definitively and solely linked to e-cigarette use. Cases of severe acute bronchiolitis have been reported in vapers, but researchers note these represent a distinct injury pattern compared to the classic occupational form seen in factory workers.

This does not mean vaping carries no respiratory risk. It means the specific claim that vaping inevitably causes popcorn lung is not supported by confirmed clinical evidence at the concentration levels found in regulated consumer products. Responsible producers should understand this distinction clearly.

The Replacement Challenge And Why It Requires Careful Management

This is where many producers, including some very well-intentioned ones, run into difficulty.

The most obvious substitute for diacetyl in creamy and custard profiles is acetoin. Unlike diacetyl and its close chemical cousin 2,3-pentanedione, acetoin does not share the same reactive alpha-dicarbonyl structure that causes airway damage. This makes it a genuinely more favorable starting point for reformulation, and health bodies including NIOSH have noted it as less hazardous than the diketones it replaces.

However, acetoin comes with one important caveat that producers must understand: it is chemically unstable in e-liquid over time. Research has shown that acetoin can slowly oxidize during storage and convert into diacetyl, particularly in the presence of nicotine and in slightly alkaline conditions. This means a formula that is correctly diacetyl-free on the day it is made may not remain diacetyl-free after months of storage on a shelf or in a consumer’s hands.

This is not a reason to abandon acetoin-based formulations. It is a reason to manage them properly. The difference between a safe acetoin-based product and a problematic one comes down entirely to one thing: testing.

Why Testing Is the Real Answer

A producer who eliminates diacetyl, replaces it with acetoin, and then puts the product on a shelf without further verification has only solved half the problem. A producer who does the same thing and then tests finished batches across the expected shelf life of the product has genuinely solved it.

This is where GC-MS testing becomes the most important tool available to any serious e-liquid producer. Gas chromatography–mass spectrometry breaks a liquid down into its individual molecular components with extraordinary precision. It can detect diacetyl at trace levels that no other affordable method can identify. It can confirm that an acetoin-based formula is performing as intended, and flag if oxidation has begun producing diacetyl during storage.

For Indonesian producers, access to this level of testing has historically been a significant barrier. The equipment alone costs between 100 million and 500 million rupiah, requires trained specialist staff, and demands validated testing methodologies to produce results that mean anything. Most producers in this market have had no practical way to verify what is actually in their finished products at a molecular level.

What This Means for Your Business

The producers who will build lasting credibility in this market with consumers, with international buyers, and with regulators as oversight in Indonesia inevitably develops are those who can demonstrate not just that they intend to make safe products, but that they can prove it batch by batch.

Reformulating away from diacetyl is the right first step. Using acetoin-based systems as part of a thoughtfully developed creamy flavor profile is a scientifically sound approach. But pairing that formulation work with verified GC-MS testing transforms a good intention into a documented safety commitment.

For consumers, this means genuine protection rather than assumed safety. For producers, it means the ability to stand behind your product.

The Bottom Line

Popcorn lung is a real disease caused by prolonged inhalation of diacetyl at high concentrations. The evidence that regulated e-liquid products at consumer exposure levels directly cause this disease remains unconfirmed. But the precautionary case for removing diacetyl from formulations is strong, the regulatory trend globally is unambiguous, and the reputational risk of being associated with the issue is real regardless of where the science ultimately lands.

The answer for Indonesian producers is not to panic about popcorn lung, and not to ignore it either. It is to take a methodical approach: reformulate thoughtfully using safer chemical pathways, understand the stability limitations of those replacements, and verify your work with proper analytical testing.

FAQ

Does vaping actually cause popcorn lung?

This is one of the most repeated claims in public health discussions around vaping, and the honest answer is that the science does not currently support it as a straightforward fact. Popcorn lung, the common name for bronchiolitis obliterans, was first identified in factory workers who were inhaling heavily concentrated diacetyl fumes for hours every day over a period of years. The concentration levels involved were enormous compared to what is found in consumer e-liquid products. Despite diacetyl also being present in conventional cigarette smoke at levels hundreds of times higher than in e-cigarette aerosol, bronchiolitis obliterans has never emerged as a recognized smoking-related disease. To date, medical literature has not produced confirmed clinical cases of the condition definitively linked solely to e-cigarette use. This does not mean vaping is risk-free, but it does mean the specific popcorn lung claim goes beyond what current evidence actually confirms.

If diacetyl is banned in regulated markets, why is it still a concern for Indonesian producers?

Diacetyl is indeed banned in e-liquids across the UK and European Union, and most reputable manufacturers have removed it from their formulations. The concern for Indonesian producers comes from two directions. First, not all flavor concentrates circulating in the Indonesian market have been properly screened, and testing of local samples has found diacetyl-related compounds present in flavors where they were not declared. Second, and more technically important, is the precursor problem. A common substitute called acetoin is widely used as a safer replacement because it has a different chemical structure from diacetyl. However, research has shown that acetoin is chemically unstable in e-liquid over time and can slowly oxidize into diacetyl during storage, particularly in the presence of nicotine. A product that is genuinely diacetyl-free on the day it is manufactured may not remain so after several months on a shelf. This means the label alone is not sufficient assurance, and only regular GC-MS testing across the shelf life of the product provides a reliable answer.

What are the safer alternatives to diacetyl for creamy and custard flavor profiles?

The most scientifically sound approach for manufacturers who want to avoid diacetyl and its structural analogues entirely is to work with lactones. These are naturally occurring cyclic esters that provide dairy, peach, and coconut notes without the reactive chemical structure that makes diacetyl problematic for inhalation. Delta-decalactone delivers sweet, milky, and creamy notes with a soft peach character. Gamma-nonalactone provides a stronger coconut and fatty dairy quality. Delta-tetradecalactone is particularly effective at replicating the sensation of richness and full-fat creaminess, and research into the molecular composition of cream has identified it as a key contributor to that retronasal creamy perception. These lactone-based approaches require more sophisticated flavor chemistry than simply using a diketone compound, which is why they tend to be found in products from more technically capable manufacturers rather than budget operations. The result, however, is a creamy profile that does not carry the same inhalation risk profile as the compounds it replaces.

How can a producer verify that their current creamy or custard flavor is actually free of diacetyl and its precursors?

The only reliable method is GC-MS analysis, which stands for gas chromatography–mass spectrometry. This is the analytical technique that separates a flavor mixture into every individual compound it contains and identifies each one based on its unique molecular signature. It can detect diacetyl at trace levels that no other commonly available testing method can identify, and it can also flag the presence of acetoin so that the potential for future diacetyl formation through oxidation can be assessed. A standard sensory check or a supplier declaration of diacetyl-free status is not a substitute for this kind of analysis. Supplier declarations reflect the formula as it was made, not as it exists after months of storage. GC-MS testing of finished product samples at the time of manufacture and at intervals across the expected shelf life is the only approach that gives a producer a genuinely defensible answer to the question of whether their product contains diacetyl or compounds that will become diacetyl over time.

April 19, 2026
Where Does That Vape Flavor Actually Come From?

A plain-language look at how flavors are made, what goes into your e-liquid, and what that means for the air you breathe.

Have you’ve ever wondered what gives a vape its mango taste, or how a flavor can smell exactly like fresh-baked custard? Most people assume it starts with real fruit in a factory somewhere. The truth is more interesting, and more precise, than that.

Part 1: Building a flavor from scratch

One of the biggest myths in the industry is that it takes “trucks of bananas” to make banana flavor. In reality, the molecules responsible for that familiar smell are recreated in a lab with extraordinary accuracy, at a tiny fraction of the cost and effort of extracting them from real fruit.

Flavors, whether in food, drinks, or e-liquids, are fundamentally about molecules. Every scent and taste you experience comes down to specific chemical compounds interacting with your nose and tongue. Modern flavor chemists have mapped these compounds and learned to recreate them synthetically.

The star molecules behind fruity flavors are called esters. They’re made by combining two simpler chemicals (an acid and an alcohol) in a controlled reaction. The result is a pure, stable molecule that smells and tastes identical to the one found in nature. Ethyl butyrate, for example, gives you that bright pineapple-banana note you’ll recognize instantly.

There are two ways to get these molecules:

Natural extraction means distilling the compound from real fruit or plant material. It’s expensive, seasonal, and the result often contains trace compounds from the source material that can affect consistency.

Synthetic synthesis means building the molecule step by step in a laboratory. The end product is chemically identical to what nature produces, but far purer, more consistent, and up to 40 times cheaper to produce.

This is why almost all commercial flavor production, including the flavors used in reputable e-liquid manufacturing, relies on synthetic chemistry. It allows producers to hit a purity of 99% or higher with every single batch, something that’s nearly impossible with natural extraction. “Artificial” in this context doesn’t mean inferior. Often, it means cleaner.

Part 2: The most common flavor molecules in your vape

Thousands of e-liquid formulas have been analyzed by researchers. A handful of compounds show up again and again across the industry:

Vanillin is the molecule behind sweet, creamy vanilla notes it appears in roughly 42% of products analyzed. Ethyl butyrate, responsible for pineapple and banana notes, appears in around 41%. Ethyl maltol, which gives cotton candy and caramel warmth, shows up in about 31% of formulas. Benzyl alcohol, with its faint almond sweetness, appears in roughly 32%, and gamma-decalactone, which provides peach and coconut character, is found in about 23%.

Each choice is selected because it hits a specific sensory note reliably. Premium flavor houses blend dozens of these compounds in precise ratios to create layered, complex profiles, which is why a well-made e-liquid can taste noticeably richer than a cheap one using only one or two base molecules at high concentration.

Part 3: From molecule to bottle — how e-liquid is actually made

Step 1: Sourcing pharmaceutical-grade ingredients. Reputable producers use USP-grade propylene glycol (PG) and vegetable glycerin (VG) as the two carrier liquids. These must meet pharmaceutical purity standards before any flavor is added.

Step 2: Adding the flavor concentrate. The flavor molecules are blended into the PG/VG base. PG is thinner and carries flavor efficiently; VG is thicker and responsible for visible vapor production. The ratio between them determines how the liquid performs in different devices.

Step 3: Adding nicotine, if applicable. Nicotine is measured and added with precision. Errors here are serious — which is why trustworthy producers test every batch with lab equipment rather than estimation.

Step 4: Steeping. The mixed liquid is rested for days or even weeks. This allows the flavor molecules to settle into equilibrium, rounding out any sharp or unbalanced notes. High-end labs monitor this stage carefully to prevent unwanted chemical changes occurring during storage.

Step 5: Lab testing before bottling. GC-MS testing (gas chromatography–mass spectrometry) breaks the liquid down into its individual molecular components and verifies that no harmful compounds are present. This is the step that separates genuinely compliant producers from those cutting corners on cost.

Part 4: A word on safety and why “food-safe” isn’t the whole story

This is where flavor production for vaping gets genuinely different from the food industry. Most flavor molecules carry a food-safe designation, meaning they’ve been approved for eating and drinking. But inhaling a substance and swallowing it are not the same thing biologically, and this distinction matters enormously.

When you swallow a compound, it passes through your stomach, an acidic, highly protective environment, and then through your liver, which processes and neutralizes many chemicals before they ever reach your bloodstream.

When you inhale a compound, it goes directly into your lungs. The lungs have a massive surface area, extremely thin membranes, and limited ability to break down chemicals the way the liver does. The compound enters your bloodstream almost immediately, bypassing the body’s main detoxification system entirely.

This is why responsible producers don’t simply reach for any food-approved ingredient and call it done. They specifically test for inhalation safety and avoid compounds (even common food flavors) that are known to cause irritation or damage to lung tissue at elevated concentrations.

A well-known example of this challenge is diacetyl. This is the molecule responsible for rich, buttery, and creamy flavor notes. It is perfectly safe to eat, found naturally in butter, beer, and coffee. But when inhaled in quantity over time, it has been linked to serious scarring of the small airways. It is now restricted or banned in regulated markets, and quality producers avoid it entirely. The ongoing challenge for flavor scientists is finding substitutes that are both safe to inhale and still deliver that same sense of richness and depth. It is harder than it sounds, and it is exactly the kind of problem that separates serious flavor houses from those simply chasing the cheapest ingredient available.

The bottom line

Flavors in quality e-liquids are precise, lab-synthesized molecules. Synthetic does not mean unsafe. Often it means purer and more consistent than anything extracted from natural sources. Food-safe labels do not automatically translate to safe to inhale, and responsible producers account for that difference. The gap between a quality product and a cheap one often comes down entirely to lab testing and ingredient sourcing.

FAQ

Is synthetic flavor the same as the flavor found in real fruit, or is it an inferior chemical substitute?

This is one of the most common misconceptions about how modern flavor chemistry works. Synthetic flavor molecules are not approximations of natural ones. They are chemically identical to the compounds found in the fruit itself. The molecule responsible for banana aroma, ethyl butyrate, is exactly the same whether it was extracted from an actual banana or built in a laboratory from butyric acid and ethanol. The difference is not in the molecule but in how it was obtained. Synthetic production is actually more consistent and often purer than natural extraction, which can introduce trace compounds from the source material that affect stability and quality. When a reputable flavor house produces a synthetic ester at 99% purity, the result is cleaner and more predictable than what natural extraction typically delivers. The word artificial carries negative connotations that the chemistry does not support.

If flavor ingredients are food-safe, why does it matter what concentration is used in an e-liquid?

Food safety assessments are conducted specifically for substances that are eaten and processed through the digestive system. When a compound is swallowed, it passes through the stomach, which provides an acidic protective environment, and then through the liver, which breaks down and neutralizes many chemicals before they reach the bloodstream. Inhalation bypasses all of this entirely. A compound that is inhaled reaches the lungs directly, crosses into the bloodstream almost immediately through the alveolar membrane, and arrives at the brain and other tissues faster and in higher concentrations than the same compound would if swallowed. The lungs have limited capacity to metabolize foreign chemicals compared to the liver. This means that a substance perfectly safe to consume in food can behave very differently when inhaled repeatedly at the concentrations found in e-liquid, which can be thousands of times higher than the levels present in natural fruit. Food-safe and inhalation-safe are two separate assessments, and assuming one covers the other is where the problem begins.

What makes one e-liquid flavor taste noticeably richer and more complex than another?

The difference almost always comes down to the depth and precision of the flavor formulation rather than the quality of a single ingredient. Premium flavor houses blend dozens of individual compounds in carefully calculated ratios to create layered profiles where different notes emerge at different points during inhalation and exhalation. Budget products tend to rely on a small number of inexpensive compounds at high concentrations, which produces a flat, one-dimensional taste that can also be harsher on the throat. The interaction between compounds matters as much as the compounds themselves. Adding small amounts of vanillin to a fruity blend, for example, enhances the perception of ripeness without the mixture tasting of vanilla. Ethyl maltol smooths the sharp edges of acidic citrus notes and adds a perception of sweetness without additional sugar. These synergistic relationships between molecules are what separates a well-engineered flavor from a simple one, and they require both scientific knowledge and sensory expertise to develop correctly.

How does a manufacturer know whether the flavors they are using are safe to inhale, not just safe to eat?

The honest answer is that without proper laboratory testing, they often do not. The most reliable method for verifying the safety of an e-liquid flavor at the compound level is GC-MS analysis, which stands for gas chromatography–mass spectrometry. This technique separates the flavor mixture into every individual molecule it contains and identifies each one, allowing a complete picture of what is actually present in the formula rather than what the supplier says is present. It can detect compounds like diacetyl at trace levels, identify CMR classified substances that should not be in an inhalation product, and flag anything that falls outside the permitted parameters for the markets the product is intended for. Beyond testing at the time of manufacture, stability testing across the expected shelf life of the product is also important, because some compounds that are safe when a product is first made can change chemically during storage. Responsible manufacturers conduct both, and they work with flavor suppliers who provide full technical documentation rather than general assurances.

April 19, 2026
Indonesia’s Tobacco Trap: Big Corporations Write the Rules, Vape Fights Back

Indonesia has a smoking problem that most governments would consider a national emergency. According to the World Health Organization, Indonesia’s smoking rate ranks fifth in the world, with 38.7% of people over the age of 15 using tobacco in 2025. According to the government’s own Indonesia Health Survey, 70.2 million people smoked in 2023, including 5.2 million teenagers and preadolescents. Nicotine Insider The five leading causes of death in Indonesia are all driven or worsened by tobacco.

And yet, the government just froze cigarette taxes for the second year in a row.

This is not an accident. It is the result of one of the most deeply embedded industry-government relationships in the world, one that shapes every policy decision touching nicotine in Indonesia, including the rules that govern vape.

The Tobacco Industry Runs the Room

Indonesia ranks among the top 10 countries most influenced by the tobacco industry, according to the Global Tobacco Industry Interference Index 2025. Nicotine Insider That ranking is not abstract. It plays out in concrete, documented ways.

In early October 2025, Indonesia’s Minister of Finance announced that the country would raise neither its cigarette excise tax nor the recommended minimum selling price of cigarettes in 2026, marking the second consecutive year the tobacco levy remained unchanged despite already ranking among the lowest in the world. The announcement came days after a reported meeting with the Unified Tobacco Manufacturers Associations of Indonesia (GAPPRI), which includes representatives from PT Djarum, PT Gudang Garam Tbk, and PT Wismilak Inti Makmur Tbk. Nicotine Insider

The justification offered was that raising prices would widen the gap between legal and illegal cigarettes and push smokers toward illicit products. A CISDI study found, however, that most illicit cigarettes in Indonesia are not smuggled from outside but are locally produced, meaning the illicit market problem is largely a domestic enforcement issue, not a pricing one. Nicotine Insider The tax freeze argument protects industry margins, not public health.

A draft regulation mandating 50% pictorial health warnings on tobacco and nicotine product packages has stalled amid industry pressure. Tobacco taxes have not risen in two years, with companies citing supposed threats to jobs and tobacco farmers’ livelihoods. Nicotine Insider

Big tobacco has substantially influenced both the policy decision process and public perceptions of its importance to the economy. WHO-FCTC ratification reluctance and the adoption of only partial tobacco control regulation is clear evidence of the power imbalance between the tobacco industry and tobacco control. Global Law Experts Indonesia remains one of the few major economies that has still not ratified the WHO Framework Convention on Tobacco Control.

The Rules Are Not Neutral

Here is the paradox that every Indonesian vape brewer lives with: cigarettes are sold on every street corner, individually if you want, to anyone who shows up. Vape shops must be located at least 200 meters from schools. Online vape sales are required to incorporate age-verification processes, though in practice most online stores are not currently implementing such verification. Ecigator The compliance burden falls almost entirely on the emerging industry, not the established one.

Government Regulation No. 28 of 2024 subjects electronic cigarettes to the same regulations as conventional cigarettes, limits single-stick cigarette sales, and raises the minimum age for purchasing tobacco products from 18 to 21. Thecontinuumofrisk Treating vaping and combustible cigarettes identically under regulation sends a clear message to consumers: they are equally harmful. The science says otherwise.

The science on harm reduction is consistent. Reviews by Public Health England and the Royal College of Physicians conclude that vaping is substantially less harmful than smoking. Japan’s adoption of heated tobacco products has coincided with one of the steepest declines in cigarette sales ever recorded in a major market. Sweden’s long acceptance of reduced-risk nicotine products has driven smoking rates to among the lowest in the world. These are measurable, population-level outcomes. They are routinely ignored in Indonesian policy discussions.

The Vape Industry: Small, Young, and Fighting

Against this backdrop, Indonesia’s vape sector has built something remarkable. Over 200 local vape manufacturers and traders operate in the country. Indonesia has the region’s highest consumption potential, with over 5 million adult users. The market is projected to reach IDR 22.5 trillion (approximately USD 1.4 billion) by 2025, with vape retail expanding at an annual growth rate of 35% in store openings. Vape-ecigs

Philip Morris International announced a USD 330 million investment via its subsidiary Sampoerna to build its seventh global smoke-free product facility in Karawang, West Java, making Indonesia one of the most attractive vape investment destinations in the region. Vape-ecigs Even Big Tobacco is betting on the transition, just not in a way that benefits local Indonesian brewers.

This is the generational tension at the heart of the market. The large multinationals have the capital, the regulatory relationships, and the lobbying infrastructure to navigate the compliance environment. Local brewers, the ones mixing flavors in Bandung and Surabaya and building loyal customer bases one recipe at a time, are the ones most exposed to every new requirement, every HS code change, every Halal deadline, every BPOM rule update.

Open systems, the product category where local brewers compete, account for 70% market share in Indonesia. Vape-ecigs This is a locally-driven market. The culture of Indonesian vaping was not built by multinationals. It was built by small producers, independent shops, and communities of adult smokers who found a better option.

The Regulatory Squeeze and What It Actually Does

Although Indonesia has strengthened tobacco control with Law No. 17 of 2023 and Government Regulation No. 28 of 2024, implementation is blunted by massive industry interference and opposition. Nicotine Insider The result is a regulatory environment that looks active on paper but works selectively in practice.

Vape gets the compliance pressure. Cigarettes get the tax freeze.

When vape becomes more expensive or harder to access through legal channels, price-sensitive consumers do not quit nicotine. They return to cigarettes, or they buy from informal suppliers. Both outcomes are worse for public health than a well-regulated vape market. The Indonesian government’s own target is to reduce the smoking rate among adolescents aged 10 to 21 to 12.4% by 2025, with targets declining to 8.4% by 2029. Global State of Tobacco Harm Reduction You cannot hit those numbers while simultaneously making the only viable alternative to cigarettes harder to buy.

Why This Fight Matters Beyond Indonesia

Indonesia is the fourth-largest tobacco-consuming country in the world. What happens here matters globally. If Indonesia manages to build a functioning, compliance-driven vape market that genuinely draws smokers away from combustible cigarettes, it becomes a model for the rest of Southeast Asia, a region where full bans have pushed vaping underground and left cigarette dominance untouched.

The vape industry in Indonesia is young and underfunded compared to the giants it is competing against. But it has something Big Tobacco does not: a product that is genuinely better for the people using it. That is not a marketing line. It is the scientific consensus, backed by decades of evidence from markets that chose harm reduction over prohibition.

The fight for fair regulation in Indonesia is not just a business issue. It is a public health issue. And right now, the rules are not written in the public’s favour.

March 24, 2026
What Is Actually Inside Your Vape Flavor?

You know your formula. Base VG and PG, nicotine at the right strength, flavor at the right percentage. It tastes the way it should. Consumers like it. It sells.

But if someone asked you to name the specific chemical compounds inside that flavor concentrate, and confirm whether each one is permitted under international regulatory standards, could you answer?

Most manufacturers cannot. Not because they are careless, but because that information was never given to them.

Flavor Is Not One Ingredient. It Is Dozens.

This is the part that surprises many people outside of flavor chemistry. When you add a flavor concentrate to your base, you are not adding a single substance. You are adding a complex mixture that can contain anywhere from a dozen to several hundred individual chemical compounds, each present at a specific concentration, each with its own regulatory history.

Some of those compounds are simple fruit esters (entirely safe, well-studied, and permitted everywhere). Others sit in more complicated territory. A handful may carry classifications that would prevent your finished product from entering certain markets entirely, regardless of how good it tastes and regardless of how small the concentration is in your final bottle.

These compounds are not necessarily dangerous to your consumers at the levels found in a finished e-liquid. The question is whether your flavor formula contains compounds that are prohibited. If it does, the product cannot enter that market.

CMR

CMR stands for Carcinogenic, Mutagenic, or Reprotoxic. It is the classification system used by the European Chemicals Agency to identify substances that may cause cancer, genetic damage, or harm to reproductive health.

The classification runs in two categories. Category 1 means the substance is confirmed harmful in humans. Category 2 means it is suspected harmful based on strong scientific evidence.

Under EU REACH regulations and IFRA guidelines for flavor formulation, CMR Category 2 substances are not permitted in food-grade or inhalation-grade flavor compounds. Not permitted at low concentrations. Not permitted at trace levels. Not permitted at all.

This matters for Indonesian producers for a reason that goes beyond Europe. As ASEAN regulatory frameworks continue to develop and harmonize with global standards, the CMR classification system is increasingly being adopted as the reference point for what is and is not acceptable. What is outside the scope of Indonesian regulation today has a documented tendency to come within scope within a few years.

What Has Been Found in the Indonesian Market

GC-MS testing (gas chromatography–mass spectrometry), the analytical method that separates a flavor mixture into every individual compound it contains, has been conducted on flavor samples circulating in the Indonesian market, including products commonly used in the Bandung and West Java production clusters.

The findings are worth understanding in detail.

Diphenyl oxide and rose oxide have both been classified as CMR Category 2 reprotoxic substances. Under EU REACH and IFRA standards, neither is permitted in food-grade flavor formulation at any concentration. In testing of Indonesian market samples, diphenyl oxide has been detected at concentrations ranging from 0.2% to 0.6% within the flavor concentrate itself. This is not a trace amount. It is a measurable presence of a compound that is categorically prohibited in regulated markets.

Heliotropine, also known as piperonal, is a widely used aroma compound with a sweet, floral, slightly spicy character that appears frequently in dessert and tobacco flavor profiles. It sits on the IFRA restricted list and faces increasing regulatory pressure in European markets. International buyers sourcing from the region are increasingly requiring confirmed zero inclusion of this compound as a condition of purchase.

Methyl salicylate carries a specific restriction in the EU for products accessible to consumers under 18 years of age. For any producer with ambitions in international retail, its presence requires documented justification and in many contexts is simply not acceptable regardless of the documentation provided.

The appearance of these examples and other compounds in Indonesian market samples is not isolated. It reflects a broader pattern that arises when flavor supply chains prioritize cost and sensory performance without systematic regulatory screening, which describes the majority of flavor supply in this market today.

Why Your Product Selling Well Is Not the Whole Answer

The most common response to this information is a reasonable one: my product is selling, my consumers are happy, and I have had no complaints. Why does this matter?

It matters for two main reasons.

The first is regulatory access. Export markets do not evaluate whether your finished product causes harm to consumers. They evaluate whether your formula contains prohibited compounds. A product with excellent taste, strong consumer reviews, and years of domestic sales history will be turned away at the border of a regulated market if the flavor formula contains a banned substance. The documentation gap that exists in most of the Indonesian market today is a direct barrier to export growth, and that barrier is becoming more consequential as the industry matures.

The second is trajectory. Regulations move in one direction. The compounds being screened out of EU and UK markets today will increasingly come under scrutiny in ASEAN markets over the next three to five years. Manufacturers who identify and address these issues now are managing a planned transition. Manufacturers who discover them later are managing a production disruption, often at a point when they have significant inventory, active customer commitments, and no time to reformulate carefully.

The Simple Question That Reveals a Great Deal

You do not need laboratory equipment to take a first step. You need one question to ask your current flavor supplier:

Can you provide a technical datasheet showing the full chemical compound composition of this flavor, including the regulatory status of each compound under EU REACH and IFRA standards?

A supplier with properly screened, compliant flavor formulations will have this document. It will list every compound present, the concentration at which it appears, and its classification under the relevant international frameworks.

If the response you receive is a general assurance that the product is safe, a statement that all ingredients are food-grade, or simply silence and delay, that response is itself meaningful information. It tells you that systematic regulatory screening has not been part of how that flavor was developed or sold to you.

What Verified Compliance Actually Looks Like

Producers who have moved toward verified compliance work differently from those who have not. Their flavor suppliers provide full compound-level documentation. Their formulations have been screened against CMR classifications, IFRA restriction lists, and the specific prohibited substance schedules of their target export markets. When a buyer in Australia, the UK, or Europe asks for regulatory documentation, they can provide it.

This is not a theoretical advantage. As large domestic retailers and international distributors increase their presence in the Indonesian market, documentation requirements that were once only relevant for export are beginning to appear as conditions of domestic trade as well.

The foundation of that position is knowing, at the compound level, what is in your flavor. Not assuming it is fine. Knowing.

A Practical Starting Point

For producers who want to understand their current position, GC-MS analysis of your existing flavor concentrates is the most direct route to an honest answer. A full analysis will identify every compound present in your formula, map each one against its regulatory classification, and give you a clear picture of where you stand relative to the markets you are targeting or planning to target.

We work with an R&D laboratory that conducts this analysis and produces a full regulatory report covering EU REACH, IFRA, and key export market requirements. If you are a producer in Indonesia who wants to understand what is actually in your current flavors before someone else asks you that question, we are happy to arrange that analysis and walk you through the results.

The industry is growing. The markets available to Indonesian producers are expanding. The producers who move into that growth with documentation behind them are in a fundamentally stronger position than those who move into it hoping the question never comes up.

The question will come up. The time to find the answer is now, while you still have the option to choose how you respond to it.

March 20, 2026
Indonesia’s 2026 Vape Regulations: What Every Liquid Manufacturer Needs to Know

July 26, 2026 is a date that every liquid manufacturer in Indonesia should have marked on their calendar. Government Regulation No. 28 of 2024 and BPOM Regulation No. 18 of 2025 come into full effect, bringing with them the most significant overhaul of Indonesia’s e-cigarette regulatory framework in more than a decade.

Most industry discussion has focused on packaging size changes. That matters, and we will cover it. But there is a second dimension to these regulations that has received less attention with more consequential change for Vape liquid manufacturers.

This article explains what is changing, what needs to be prepared, and the concrete steps you can take now to ensure your business not only survives July 2026 but is in a stronger position after it.

What PP 28/2024 Actually Changes

PP 28/2024 is the implementing regulation for Indonesia’s Omnibus Health Law No. 17 of 2023. It replaces Government Regulation No. 109 of 2012 and brings e-cigarettes under the same regulatory framework as conventional tobacco products for the first time in a structured, enforceable way.

Key changes

The packaging size restriction is the most widely discussed change. After July 26, 2026, open-system e-cigarette liquid may only be sold in 10ml and 20ml containers. The 30ml, 60ml, and larger formats that currently dominate the Indonesian market will no longer be permitted. With less than six months remaining, manufacturers who have not yet adjusted their packaging, licensing, and distribution strategy are already behind.

The minimum purchase age has been raised to 21. The previous threshold was 18. This new standard brings Indonesia in line with stricter international frameworks and has direct implications for how products are marketed and where they can be sold.

Online sales restrictions have been introduced. PP 28/2024 prohibits the sale of tobacco products and e-cigarettes through web services, commercial electronic applications, or social media platforms without age verification. For brands that have built distribution channels through e-commerce or social media, this requires a fundamental rethink of their sales strategy.

Proximity restrictions now apply. PP 28/2024 prohibits the sale of electronic cigarettes within 200 meters of children’s educational facilities or playgrounds.

Advertising requirements have been tightened significantly. Social media advertising for vape products is now prohibited. Requirements for outdoor, print, and broadcast advertising have also been considerably tightened.

PerBPOM 18/2025: The Regulation Inside the Regulation

Issued in July 2025 with the same July 26, 2026 effective date, BPOM Regulation No. 18 of 2025 is where compliance obligations become most technical and most consequential for flavor manufacturers and liquid producers.

There are two provisions in PerBPOM 18/2025 that matter most.

The first is the ingredient disclosure requirement. For the first time, tobacco product manufacturers and distributors are required to disclose the full list of ingredients used in their products to BPOM. This includes all chemical compounds, flavorings, and other substances.

What this means in practice is straightforward. If your flavor supplier has never provided you with a technical datasheet detailing the chemical composition of their formula, you now have a regulatory obligation you may not be equipped to meet.

The second is additive safety testing. E-cigarette manufacturers are prohibited from using additives unless scientific evidence demonstrates that those additives are harmless to health. E-liquids must be tested for banned additives before they are marketed and during circulation, with cross-verification by two different laboratories.

This is not an administrative formality. It requires demonstrable, laboratory-verified evidence that every additive in your formula meets the safety standard. Without knowing what compounds are in your flavor in the first place, you cannot begin to satisfy this requirement.

What Needs to Be Prepared and in What Order

Facing several regulatory changes simultaneously can feel overwhelming. What helps is separating the obligations by type and working through them in sequence, starting with the most foundational.

The first step is understanding what is currently in your formula. Before you can meet the ingredient disclosure obligations of PerBPOM 18/2025, before you can submit a pre-market notification, and before you can verify additive safety, you need to know the complete chemical composition of every flavor you are using. This is the foundation of everything else. Without it, the subsequent steps cannot be done correctly.

The way to get this information is to request a technical datasheet from your flavor supplier. A proper document will list every compound present in the formula, the concentration at which it appears, and its regulatory status under the relevant international standards. If your supplier cannot provide this document, it is worth considering whether they are the right partner for the regulatory environment that is coming.

If documentation cannot be obtained from your supplier, the alternative route is independent GC-MS analysis of the flavor samples you are currently using. This testing separates the flavor mixture into every individual compound it contains and provides a complete picture of what is actually in your formula. The results can then serve as the basis for ingredient disclosure to BPOM.

The second step is assessing the regulatory compliance status of each identified compound. Knowing what is in your formula is only half the answer. The other half is knowing whether each compound is permitted under the applicable regulations. For the domestic market, the reference point is PerBPOM 18/2025 and the list of additives prohibited by BPOM. For export markets, the standards are different and generally stricter, with EU REACH and IFRA guidelines being the most internationally relevant frameworks.

There are several classifications worth understanding in this context. CMR stands for Carcinogenic, Mutagenic, or Reprotoxic, the system used to identify substances that may cause cancer, genetic damage, or harm to reproductive health. Category 1 means confirmed harmful in humans. Category 2 means suspected harmful based on strong scientific evidence. Under EU REACH and IFRA standards, CMR Category 2 substances are not permitted in food-grade or inhalation-grade flavor formulations at any concentration.

Testing conducted on samples from the Indonesian market has found several problematic compounds appearing repeatedly. Diphenyl oxide has been detected at concentrations between 0.2% and 0.6% within flavor concentrates and is classified as CMR Category 2 reprotoxic. Rose oxide is also classified CMR Category 2 and has been found in samples at low but non-trivial concentrations. Heliotropine, also known as piperonal, is on the IFRA restricted list and is increasingly being rejected by international buyers. Methyl salicylate carries specific restrictions for products accessible to consumers under 18 in EU markets.

The important thing to understand is that the presence of these compounds in Indonesian market samples does not necessarily mean your product is dangerous to consumers at the final use level. It means the formula contains compounds that are categorically prohibited in regulated markets, which will prevent the product from entering those markets, and which may fail the additive safety testing required by PerBPOM 18/2025.

The third step is adjusting packaging and obtaining the necessary licensing. The transition to 10ml and 20ml formats requires label redesign, re-filing of product registrations for affected SKUs, and managing existing stock of larger formats. Any change to a formula, packaging, or manufacturer also requires a new pre-market notification submission to BPOM. Ideally, packaging adjustments and any formula adjustments are handled together in a single notification cycle rather than two separate cycles that consume more time and cost.

The fourth step is building documentation for ingredient disclosure. PerBPOM 18/2025 requires full ingredient disclosure to BPOM. The documentation you need for this includes the complete chemical composition of every flavor used, laboratory test evidence for every additive, and cross-verification from two different laboratories. Building this documentation from scratch takes time. Manufacturers who start the process now will be in a significantly stronger position than those who wait until the deadline is close.

Why This Is Also About Opportunity, Not Just Compliance

There is another way to look at all of this. Stricter regulation consistently produces market consolidation. Manufacturers who cannot meet the new requirements exit the market. Those who do meet them gain a larger share of the remaining demand, plus access to customer segments that were previously out of reach.

Manufacturers with complete compliance documentation have several concrete advantages. They can supply large domestic retailers who are increasingly requiring regulatory documentation as a condition of doing business. They can respond to export inquiries that already have compliance requirements higher than those currently applicable in Indonesia. They can demonstrate to international buyers that their formulas are clean and documented

All of this starts from a single foundation: knowing what is in your formula and having the documentation to prove it.

How We Can Help

We are a flavor distributor in Indonesia working with a certified R&D laboratory in France. One of the things that distinguishes us from most flavor suppliers in this market is that we provide access to GC-MS testing and complete technical documentation as a standard part of what we offer.

FAQ

What is the single most important deadline every Indonesian liquid manufacturer needs to know about in 2026?

July 26, 2026 is the date when both PP 28/2024 and PerBPOM 18/2025 come into full effect. This is not a soft deadline or a transitional period with gradual enforcement. From that date, open-system e-liquid may only be sold in 10ml and 20ml containers, full ingredient disclosure to BPOM becomes mandatory, and additive safety testing with cross-verification from two separate laboratories is required before products can be marketed. On top of this, October 17, 2026 brings the mandatory Halal certification requirement for flavoring agents and chemical goods. Manufacturers who are not actively preparing for both of these dates right now are working with a shrinking window. The packaging transition alone requires label redesign, SKU re-registration, and stock management, and that process cannot be compressed into the final few weeks before the deadline.

What does the ingredient disclosure requirement under PerBPOM 18/2025 actually mean for a manufacturer who buys flavor from a supplier?

It means that for the first time, you are legally required to disclose to BPOM every chemical compound present in your finished product, including every substance within the flavor concentrate you are using. If your flavor supplier has only ever given you a general product description or a basic safety data sheet without a full chemical compound breakdown, you currently do not have the information you need to meet this obligation. The regulation does not distinguish between compounds you knew about and compounds you did not. The disclosure requirement covers everything that is in the product. This makes the quality of your supplier relationship and the documentation they provide directly relevant to your own legal compliance. A supplier who cannot or will not provide a full technical datasheet showing every compound and its regulatory status is a supplier who is leaving you exposed to a requirement you cannot fulfill on your own.

Are there compounds commonly found in Indonesian market flavors that could cause problems under the new regulations?

Yes, and this is something manufacturers need to understand before they submit any documentation to BPOM rather than after. GC-MS testing of flavor samples from the Indonesian market has found several compounds that carry problematic regulatory classifications. Diphenyl oxide has been detected at concentrations between 0.2% and 0.6% within flavor concentrates and is classified as CMR Category 2 reprotoxic under EU REACH standards, meaning it is not permitted in food-grade or inhalation-grade flavor formulations at any concentration. Rose oxide carries the same CMR Category 2 classification. Heliotropine, also known as piperonal, is on the IFRA restricted list and faces increasing rejection from international buyers. The presence of these compounds does not automatically mean your finished product is dangerous to consumers at the final diluted level. What it does mean is that your formula contains substances that are categorically prohibited in regulated markets, and which are likely to fail the additive safety scrutiny that PerBPOM 18/2025 now mandates domestically.

A manufacturer who wants to be compliant by July 2026 and also export to international markets. Where should they start?

The starting point is the same for both objectives: know what is in your formula. Every other step, whether it is BPOM ingredient disclosure, Halal certification, additive safety testing, or export market approval, requires this as its foundation. The practical first step is requesting a full technical datasheet from your flavor supplier covering every compound present and its regulatory status under EU REACH and IFRA standards. If that document is not available from your supplier, independent GC-MS analysis of your current flavor samples is the alternative route to the same information. Once you know what is in your formula, you can assess which products are already compliant, which require reformulation, and which suppliers are genuinely equipped to support the documentation requirements you now face. Reformulation takes time, re-registration takes time, and Halal certification takes time. The manufacturers who start this process in the first half of 2026 will complete it before the deadlines. Those who start in June will not.

March 19, 2026
Indonesia’s Positive Investment List for Foreign Investors in Specialty Ingredients and F&B

Indonesia is one of the most compelling investment destinations in Southeast Asia, and for companies in specialty ingredients, food additives, flavor manufacturing, and F&B processing, the timing has never been more relevant. A population of 280 million, a rapidly urbanizing middle class, a booming processed food sector, and a government actively courting foreign capital have combined to create a genuine window of opportunity.

But the rules matter. Understanding Indonesia’s Positive Investment List is not a formality. It is the foundation on which your entire market entry is built.

What the Positive Investment List Actually Is

Before 2021, Indonesia operated a Negative Investment List, an approach that told foreign investors what they could not do. The Positive Investment List represents one of Indonesia’s greatest liberalizations in foreign ownership limitations since the negative investment list was first introduced in the 1980s. The general principle is simple: a business sector is open to 100% foreign investment unless it is explicitly limited. Tobacco Control Laws

This framework was introduced through Presidential Regulation No. 10 of 2021, later amended by Presidential Regulation No. 49 of 2021. As of 2026, the core ownership rules remain anchored in these regulations. What changed in 2025 were implementation and licensing regulations, not the ownership list itself. China Briefing This is an important distinction. The sectors open to foreign investment have not changed. The way you navigate the process has.

In the first quarter of 2025, Indonesia attracted FDI totaling approximately USD 13.67 billion, a 12.7% increase compared to the same period the previous year. Nicotine Insider Specialty ingredients and food processing are part of why that number keeps climbing.

The Four Categories You Need to Know

Every business in Indonesia is classified into one of four investment categories. For flavor and ingredient companies, knowing which category your operation falls into determines ownership structure, capital requirements, licensing complexity, and whether you qualify for tax incentives.

Fully open sectors allow up to 100% foreign ownership with no local partnership required. Food ingredient manufacturing and industrial chemical production, including flavor concentrate manufacturing, generally fall here, subject to correct KBLI classification.

Priority sectors are business fields the government actively wants to attract. There are 246 priority business fields eligible for incentives including tax holidays, import duty exemptions, and streamlined licensing. Tobacco Control Laws Food processing with strong export orientation, R&D-linked operations, and high-value manufacturing can qualify. Fiscal incentives include a 50% corporate income tax reduction for investments between IDR 100 billion and IDR 500 billion for five years, and a 100% CIT reduction for investments above IDR 500 billion for periods between five and twenty years. Thecontinuumofrisk

Conditionally open sectors require either local partnerships, MSME cooperation agreements, or have ownership caps. There are 106 business lines in this category, covering activities that do not use advanced technology, are labor-intensive, or are characterized by special cultural heritage. Tobacco Control Laws Traditional food production using local methods can fall here.

Closed sectors are reserved for government or are entirely prohibited. Defense, gambling, and certain cultural activities are examples. Specialty ingredients and F&B manufacturing do not sit here.

KBLI Defines Your Business

The most critical practical decision any foreign investor makes in Indonesia is selecting the right KBLI code, the Indonesian Standard Business Classification number that defines every aspect of your legal and operational identity.

Your KBLI code directly determines: whether your business is eligible for foreign investment, the maximum percentage of foreign ownership allowed, which tax incentives you can unlock, and the exact licenses and permits your operation requires. World Vape Show

For specialty ingredients companies, the relevant KBLI codes span several categories depending on your specific activity. Flavor concentrate manufacturing for industrial use sits in the chemical manufacturing space. Food additive production for direct F&B application sits closer to food processing classifications. Importing and distributing specialty ingredients as a trading entity is classified differently again, and each classification carries its own ownership rules, capital requirements, and licensing paths.

All new company registrations in 2026 must use KBLI 2025, which replaced KBLI 2020 in December 2025. This applies equally to local companies and PT PMA foreign-owned entities. Vaping360 The new classification system is more granular, which is good for precision but punishing if you get it wrong. Errors in classification can cause delays across licensing, banking, and tax processes, making precise early selection essential. Ecigator

A real-world example of what happens when you get this wrong: a Singapore-based technology firm established a PT PMA using one KBLI code, then found as operations expanded that it needed additional codes not listed in the original deed. The company had to amend its Articles of Association and resubmit documentation, resulting in a three-month delay. Early inclusion of all relevant KBLI codes would have prevented the setback entirely. Ecigator

For an ingredient or flavor company planning to manufacture locally, distribute imports, and potentially conduct R&D, you likely need multiple KBLI codes from day one.

Capital Requirements in 2026

Under BKPM Regulation No. 5 of 2025, the minimum total investment for a PT PMA is more than IDR 10 billion (excluding land and buildings) for each 5-digit KBLI code per project location. The minimum paid-up capital has been reduced from IDR 10 billion to IDR 2.5 billion. The Vapers World

This two-tier structure matters in practice. You need to plan IDR 10 billion in total investment per business line, which includes machinery, equipment, working capital, and project costs. The IDR 2.5 billion is the minimum that must sit in your company bank account, and it cannot be transferred out of the company’s bank account for a minimum of 12 months from the date of deposit, though it can be used during this period for business purposes including purchasing assets, constructing buildings, and covering operational needs. Hangsen

Food and Beverage Services benefit from a specific exception: the IDR 10 billion investment is calculated per the first 2 digits of the KBLI code, per one location point. This allows F&B companies to cover a wider range of related activities under a single investment commitment. Hangsen

For investors planning to hold a long-term residence permit alongside their business, the threshold is higher. An Investor KITAS (Temporary Stay Permit) requires minimum capital of IDR 10 billion in share ownership. An Investor KITAP (Permanent Stay Permit) requires IDR 15 billion. The Vapers World

The Regulatory Layer Specific to Ingredients and Flavors

Opening a PT PMA in the right category is only the beginning. Specialty ingredient and flavor businesses in Indonesia operate under a second, parallel regulatory framework that runs alongside the investment rules.

Under BPOM Regulation No. 11/2019, there are 26 groups of food additives, each with permitted types and maximum usage limits. To use a food additive not on the approved list, a separate permit must be obtained from the Head of BPOM. BPOM Regulation No. 13/2020 on Flavored Food Additives covers ingredient types, groups, and usage of flavoring additives including flavoring adjuncts. Global State of Tobacco Harm Reduction

This means that as a foreign investor, you are simultaneously managing your investment structure through BKPM and your product compliance through BPOM. For any ingredient that requires import, you also need the correct HS code classification and the mandatory Surat Keterangan Impor (SKI) from BPOM before the product crosses the border.

Add to this the October 2026 Halal certification deadline under Government Regulation No. 42/2024, which mandates that all food additives and chemical inputs entering Indonesia must be Halal certified, and the compliance picture for a specialty ingredients business becomes clear: investment structure, product registration, import classification, and Halal certification must all be aligned before you can trade.

Importer vs. Producer API Licence

One decision that specialty ingredient investors frequently get wrong is the API (Angka Pengenal Importir) licence type. API-U (General Importer Number) can be converted to API-P (Producer Importer Number), but API-P cannot be converted to API-U. Choosing the correct API licence before starting your business in 2026 is critical to avoid restrictions later. Sp2sglobal

For a flavor or ingredient business that imports raw materials for local production, API-P is the correct path. For a trading and distribution entity that imports finished products for resale, API-U applies. Many companies need both functions, which means planning for this from the start in your KBLI structure.

OSS and the Licensing

Indonesia’s Online Single Submission (OSS) Risk-Based Approach platform, introduced in 2021, is the gateway for all business registration and licensing. A low-risk business classification means it is sufficient to begin operations primarily with a Business Identification Number (NIB). Medium-risk businesses also need a standard certificate. High-risk businesses require further licenses and verifications from relevant government agencies. Global Law Experts

Government Regulation 28 of 2025 introduced the principle of deemed approval: if authorities fail to meet statutory deadlines for complete applications, approvals are automatically granted in the OSS system. This mechanism allows investors to plan with assurance that processing delays will not indefinitely postpone project milestones. Statista

For ingredient and flavor manufacturers, the risk classification will typically be medium-high to high, given the intersection of food safety, chemical handling, and import regulations. That means you need to plan for the full licensing sequence, not just a NIB.

Conclusion

Indonesia’s market for specialty food ingredients is growing. Government initiatives promoting local ingredient production and investments in food processing infrastructure.

The investment framework is genuinely more open than it was five years ago. 100% foreign ownership in manufacturing is real and available. The incentives for qualifying priority sector investments are significant. But the complexity of getting the KBLI right, structuring capital correctly, navigating BPOM product registration, and hitting the 2026 Halal deadline simultaneously means a lot of planning.

The companies that will dominate this market over the next decade are the ones registering correctly now.

February 17, 2026
Representative Office in Indonesia 2026: What It Can and Cannot Do

Indonesia’s consumer market is one of the most compelling in Southeast Asia. A population of over 270 million people, a growing middle class, and accelerating urbanization make it a natural target for foreign companies looking to expand in the region. The first question is how do we get a foothold here without committing to a full subsidiary before we understand the market?

The representative office, known locally as a KPPA or Kantor Perwakilan Perusahaan Asing, is usually the first answer that comes up. It is fast to establish, requires no minimum capital investment, and gives your company a legal physical presence in the country. For those reasons it looks, on paper, like an ideal entry point.

The problem is that a significant number of foreign companies set up a KPPA expecting it to function as a business, only to discover that it is legally prohibited from doing the one thing they actually need: generating revenue. Understanding exactly what a representative office can and cannot do before you commit to the structure saves a great deal of time, money, and frustration.

What a Representative Office Actually Is

A KPPA is a liaison office. It exists under Indonesian law as a non-commercial entity whose purpose is to support the activities of its foreign parent company within Indonesia, without itself conducting business. The current regulatory framework governing KPPAs includes BKPM Regulation No. 5 of 2025, which reinforced the strictly non-commercial nature of this structure and clarified the activities that are and are not permitted.

The KPPA does not have its own profit-and-loss. It does not generate income. It cannot issue invoices or receive payment for goods or services. It is funded by its parent company abroad, and its activities are limited to those that support the parent’s business interests in Indonesia without constituting commerce in their own right.

This distinction sounds clear in theory, but in practice it means that many of the activities a foreign company naturally wants to do in a new market, selling products, signing supply agreements, importing goods, and bidding for contracts, are simply outside the legal scope of this entity.

What a KPPA Can Legitimately Do

Within its non-commercial boundaries, a KPPA is a genuinely useful tool and not something to dismiss. The activities it permits are valuable for any company in the early stages of understanding and developing an Indonesian market position.

Market research and competitive intelligence is a core function. A KPPA can legally employ local staff to monitor the market, map out distribution networks, analyze competitor activity, and gather the kind of ground-level information that is difficult to obtain from a head office abroad. For a company that genuinely does not yet know whether Indonesia is the right market for its products, this function alone can justify the structure.

Brand presence and relationship building are also permitted. A KPPA can lease office space, display the parent company’s branding, and maintain a visible presence that supports the credibility of the brand in local conversations. It can open local bank accounts for the purpose of covering administrative expenses. For industries where relationships with government bodies, industry associations, and major buyers take time to develop, having a local office and local staff who can attend meetings and build those relationships consistently is genuinely valuable.

Technical support and after-sales coordination are permitted where the parent company already has clients in Indonesia through other channels. A KPPA can provide technical assistance, training, and coordination support to existing customers without this constituting a new commercial transaction. For companies in manufacturing, energy, technology, or other sectors where ongoing technical support is part of the product offering, this is a meaningful capability.

Talent acquisition and work permit sponsorship are within scope. A KPPA can sponsor ITAS work permits for foreign experts who need to be legally present in Indonesia, which allows the parent company to place its own people on the ground to oversee market development activities.

What a KPPA Cannot Do

The prohibitions are equally important to understand, and they are absolute rather than subject to interpretation or workaround.

A KPPA cannot issue an invoice or receive payment for goods or services. It cannot take a purchase order or sign a commercial contract on behalf of the parent company. It cannot import physical goods because it lacks the necessary import licenses, specifically the NIB and API-U that a commercial entity requires. It cannot participate in local tenders as a primary bidder. It cannot generate any form of revenue in Indonesia.

Running commercial transactions through a KPPA is not a grey area. Under Trade Law No. 7 of 2014, doing so is a direct path to permit revocation and significant financial penalties. Indonesian authorities have become more attentive to this in recent years, partly as a result of broader efforts to improve business transparency and partly because the growth of foreign interest in the Indonesian market has made enforcement a more visible priority.

The Nominee Problem

Before discussing legitimate alternatives to the KPPA, it is worth addressing a structure that was historically used to work around its limitations and that has become significantly more dangerous in 2026.

Nominee arrangements, known locally as sewa bendera or flag renting, involve a foreign company paying a local Indonesian individual or entity to front a commercial structure on their behalf. The local person appears on paper as the owner or director, while the foreign company retains actual control of the operations and funds.

This arrangement has always carried legal risk, but recent updates to Indonesia’s Beneficial Ownership transparency requirements have made it substantially more hazardous. Authorities now have clearer tools to identify the real economic beneficiary behind a corporate structure, and nominee arrangements that are discovered expose both parties to asset confiscation and criminal liability. Beyond the legal risk, a nominee arrangement offers the foreign company no meaningful protection if the nominee chooses to retain control of bank accounts, intellectual property, or business relationships. Cases of this kind are not uncommon, and the legal remedies available to the foreign party are limited.

In 2026, nominee structures should be treated as off the table entirely, not as a calculated risk.

The Three Legitimate Paths to Commercial Activity

For foreign companies that need to actually sell products and generate revenue in Indonesia, there are three structures worth understanding.

The first is a traditional distributor relationship. This is the fastest route to market and requires no Indonesian legal entity on the foreign company’s part. A local distributor uses their own licenses to import and sell the foreign company’s products. The trade-off is visibility and control. Once your brand is in the hands of a distributor, pricing decisions, customer relationships, and market data are largely in their hands as well. If the relationship ends, market access often ends with it. For companies whose primary concern is speed and whose products do not require close management of the customer relationship, this can work well in the early stages.

The second is a PT PMA, or Penanaman Modal Asing, which is a foreign investment company established under Indonesian law. A PT PMA can be 100% foreign owned in eligible sectors and carries full commercial rights including the ability to import, invoice, sign contracts, and employ staff directly. It is the appropriate structure for a company that is committing to Indonesia as a long-term market. The barriers are real: a minimum investment plan of IDR 10 billion is required, and the establishment process typically takes several months. For a company that has not yet validated its market position, this is a significant commitment to make before the business case is proven.

The third option, which has become the preferred approach for many foreign companies entering Indonesia in 2026, is working with a professional Importer of Record or market entry partner. This model allows a foreign company to import and sell products in Indonesia without establishing any Indonesian legal entity, using the partner’s existing licenses and compliance infrastructure to handle customs clearance, BPOM or other product registrations where required, local invoicing, VAT management, and revenue remittance back to the foreign parent. It generates real sales and real market data from day one, with a fraction of the capital commitment and legal exposure of a PT PMA.

A Sequenced Approach That Makes Practical Sense

Rather than treating these options as mutually exclusive, the most effective strategy for most foreign companies is to use them in sequence as the market opportunity becomes clearer.

The first phase is market validation. Use a market entry partner or Importer of Record to begin importing and selling immediately. This generates actual revenue, real customer feedback, and a genuine understanding of where your products fit in the market. It does this with minimal upfront investment and without locking you into a legal structure that may not fit the business model that emerges.

The second phase is market presence. Once there is enough traction to justify a local team, open a KPPA to hire dedicated Indonesian staff who can build relationships, oversee the import partner, and develop the market intelligence and stakeholder connections that will matter when you are ready to scale. At this stage the KPPA functions exactly as it is designed to: as a non-commercial support structure that complements the commercial activity being handled by the partner.

The third phase is full establishment. When annual revenue in Indonesia justifies the investment commitment, transition the commercial operations into a PT PMA. At this point you have validated the market, built the relationships, and have real data to support the investment decision. The IDR 10 billion minimum is no longer a speculative commitment; it is a planned allocation against a proven opportunity.

The Practical Question to Ask Before You Choose a Structure

The right question is not which structure is easiest to set up. It is which structure matches what you actually need to do in Indonesia right now. If your goal for the next twelve months is to understand the market and build relationships without commercial pressure, a KPPA may be appropriate as a standalone first step. If your goal is to generate revenue, prove the business case, and position yourself for growth, you need commercial capability from the beginning, and that means either a distributor relationship, an Importer of Record arrangement, or a PT PMA, with the KPPA playing a supporting role rather than the central one.

The Indonesian market rewards companies that understand its regulatory environment and work within it rather than around it. Getting the legal structure right from the start is not a bureaucratic detail. It is the foundation on which everything else is built.

FAQ

Can a representative office in Indonesia sign contracts or receive payment from local customers?

No, and this is the most important limitation to understand before setting up a KPPA. A representative office is legally prohibited from conducting any commercial activity in Indonesia. This means it cannot issue invoices, receive payment for goods or services, sign commercial contracts on behalf of the parent company, or import physical goods. These prohibitions are absolute under Trade Law No. 7 of 2014, and operating commercially through a KPPA risks permit revocation and significant financial penalties. If your goal involves any form of revenue generation in Indonesia, you need a different legal structure, either a PT PMA, a distributor relationship, or an Importer of Record arrangement, to handle the commercial side of the business.

How long does it take to set up a representative office in Indonesia, and what does it cost?

A KPPA is one of the faster Indonesian legal structures to establish. The process typically takes between four and eight weeks depending on the completeness of the documentation provided and the sector the parent company operates in. There is no minimum capital requirement, which makes it significantly more accessible than a PT PMA. The main costs involved are government filing fees, notarial costs, and the ongoing operational expenses of maintaining an office and employing local staff. Because the KPPA cannot generate revenue, all of these costs must be funded by the parent company abroad, so the ongoing financial commitment needs to be factored into the decision alongside the setup cost.

What is the difference between a KPPA and a PT PMA, and how do you choose between them?

The fundamental difference is commercial capability. A KPPA is a non-commercial liaison office that can conduct market research, build relationships, and provide technical support but cannot generate any revenue. A PT PMA is a fully commercial Indonesian legal entity that can import goods, invoice customers, sign contracts, and employ staff directly, with the possibility of 100% foreign ownership in eligible sectors. The PT PMA requires a minimum investment plan of IDR 10 billion and takes several months to establish. The choice between them depends on what you need to do in Indonesia. If your immediate priority is market research and relationship building before committing to commercial operations, a KPPA may be the right first step. If you need to sell products and generate revenue from the start, a PT PMA or an Importer of Record arrangement is necessary.

Is it possible to use both a KPPA and an Importer of Record at the same time?

Yes, and this combination is increasingly common among foreign companies entering Indonesia in 2026. The two structures serve entirely different functions and complement each other well. The Importer of Record handles all commercial activity: importing goods, managing customs clearance and product registrations, invoicing local customers, and remitting revenue back to the foreign parent. The KPPA meanwhile employs a local team that oversees the relationship with the Importer of Record, builds direct relationships with key buyers and stakeholders, conducts market intelligence, and manages brand presence. This approach gives a foreign company both commercial capability and local presence from the early stages of market entry, without requiring the capital commitment of a PT PMA until the business case in Indonesia is fully proven.

February 12, 2026

Author: Petr

How Three Global Companies Came to Own the Indonesian Cigarette Market

Why Indonesia Was the Target

The Tax System That Keeps Cigarettes Cheap

Children Are the Market

What Smoking Costs Indonesia’s Healthcare System

The Corruption Layer

Indonesia Has Not Ratified the FCTC. Here Is Why.

The Bandung Vape Scene and Why It Matters

What the Bandung Brewers Are Actually Up Against

What Independent Producers Need to Do to Actually Have a Chance

When did global tobacco companies take control of Indonesia’s cigarette market, and how much did they pay?

Why are cigarettes still so cheap in Indonesia despite tax increases every year?

What is the BNN’s proposal to ban vaping and how serious is it?

What does a Bandung brewer actually need to do to survive and grow in this regulatory environment?

What CMR Means

Why This Matters for Your Business

There are two practical consequences.

The 21 Compounds on the List

The Most Important Question to Ask Right Now

What You Should Do Before July 2026

Are all 21 compounds on this list equally serious from a regulatory standpoint?

Many of these compounds are natural. Why are they classified as CMR?

My supplier says their product is food-grade. Is that enough?

Does finding a CMR compound in my flavor mean my product has harmed consumers?

What Happened at the Strait of Hormuz

The consequences spread outward in several directions simultaneously.

What This Means for Indonesian Brewers Specifically

What a More Resilient Supply Chain Actually Looks Like

The Competitive Opportunity in All of This

Where Arkadia Comes In

FAQ

How is the Strait of Hormuz closure actually affecting flavor shipments to Indonesia?

China has cancelled its VAT export rebate on nicotine. What does that mean in practice for Indonesian brewers?

With PP 28/2024 and PerBPOM 18/2025 taking effect in July 2026, what is the single most important thing a liquid manufacturer should be doing right now?

Is there a realistic way to maintain supply continuity for European flavor concentrates given the current shipping disruptions?

What Is Popcorn Lung?

The Diacetyl Problem in E-Liquid

Where the Science Gets More Complicated

The Replacement Challenge And Why It Requires Careful Management

Why Testing Is the Real Answer

What This Means for Your Business

The Bottom Line

FAQ

Does vaping actually cause popcorn lung?

If diacetyl is banned in regulated markets, why is it still a concern for Indonesian producers?

What are the safer alternatives to diacetyl for creamy and custard flavor profiles?

How can a producer verify that their current creamy or custard flavor is actually free of diacetyl and its precursors?

Part 1: Building a flavor from scratch

There are two ways to get these molecules:

Part 2: The most common flavor molecules in your vape

Part 3: From molecule to bottle — how e-liquid is actually made

Part 4: A word on safety and why “food-safe” isn’t the whole story

The bottom line

FAQ

Is synthetic flavor the same as the flavor found in real fruit, or is it an inferior chemical substitute?

If flavor ingredients are food-safe, why does it matter what concentration is used in an e-liquid?

What makes one e-liquid flavor taste noticeably richer and more complex than another?

How does a manufacturer know whether the flavors they are using are safe to inhale, not just safe to eat?

The Tobacco Industry Runs the Room

The Rules Are Not Neutral

The Vape Industry: Small, Young, and Fighting

The Regulatory Squeeze and What It Actually Does

Why This Fight Matters Beyond Indonesia

Flavor Is Not One Ingredient. It Is Dozens.

CMR

What Has Been Found in the Indonesian Market

The findings are worth understanding in detail.

Why Your Product Selling Well Is Not the Whole Answer

It matters for two main reasons.

The Simple Question That Reveals a Great Deal

What Verified Compliance Actually Looks Like

A Practical Starting Point

What PP 28/2024 Actually Changes

Key changes

PerBPOM 18/2025: The Regulation Inside the Regulation

There are two provisions in PerBPOM 18/2025 that matter most.

What Needs to Be Prepared and in What Order

Why This Is Also About Opportunity, Not Just Compliance

FAQ